rfhg_146391.1

Basic information about the TSS

---

TSS ID: rfhg_146391.1 TSS ID(Version3): hg_123715.1 hg_123717.1 hg_123714.1 hg_123716.1 hg_123713.1 hg_123712.1 Species: human Chr: chr12		Start: 6724009 End: 6724305 Strand: +
Source datasets	FANTOM5|EPD|DRA013844|PRJNA401781|PRJNA615891|PRJNA4843412 |PRJNA548673|PRJDB5282|PRJNA597322
Protocol	CAGE|TSS_database|RAMPAGE|SLIC_CAGE|NETCAGE|ReCappable-seq |C1CAGE|TIF-seq2|STRIPE-seq
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2526186,EH38E1590204)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000626119.2:0 ENST00000455113.6:0 ENST00000542150.5:0 ENST00000543155.6:0 ENST00000229251.7:0 ENST00000539735.5:0 ENST00000543170.5:0 ENST00000538410.5:0 ENST00000540408.5:0 ENST00000537022.5:0 ENST00000543939.5:0 ENST00000538375.5:0 ENST00000544725.5:0 ENST00000534947.5:0 ENST00000536872.5:0 ENST00000546229.5:0 ENST00000541866.5:0 ENST00000534877.5:0 AK128792:0 BC093015:0 AK021721:0 AF210052:0 AK001318:0 AK022488:0 BC011789:0 AB033603:0 AK292621:0 GeneID: 50813 HGNC/MGI_ID: HGNC:16758 UniProt_ID: B3KY75 F5GXT7 F5H248 F5H4U8 F5H4Z0 F5H7C6 G3XAP1 Q567U8 Q9UBW8 Nearer transcript ids and distances: ENST00000538753.5:1 ENST00000543537.5:1 ENST00000544316.1:132 AB463540:352 DQ892894:352 DQ896141:352 KJ898788:352 AB014764:352 AF193844:352 view more...

Gene_name: COP9 signalosome subunit 7A Gene_symbol: COPS7A Gene_synonyms: CSN7A Gene_source: HGNC:16758

TATA-Box annotation

---

Distance to TSS:	111
Nearest PromoterID:	NM_001164095
Entrez ID:	50813
Nearest Unigene:	Hs.530823
Nearest Refseq:	NM_016319
Nearest Ensembl:	ENSG00000111652
Gene Name:	COP9 signalosome subunit 7A
Gene Alias:	CSN7|CSN7A|SGN7a
Gene Type:	protein-coding
CpG%:	0.094595
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):	212(GTGTCTTTAAGG,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@COPS7A p2@COPS7A p3@COPS7A p4@COPS7A p5@COPS7A p6@COPS7A
Sample		p1@COPS7A	p2@COPS7A	p3@COPS7A	p4@COPS7A	p5@COPS7A	p6@COPS7A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	5.65	14.81	1.56	2.14	0.97	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	6.27	14.77	4.45	2.43	2.02	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.94	16.40	2.31	1.93	1.74	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.99	12.06	2.49	2.49	2.08	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	5.40	13.95	2.02	1.80	1.12	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.46	14.15	2.13	1.55	0.78	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	5.23	14.82	5.23	4.79	2.40	3.27
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	5.33	17.68	4.84	3.63	1.70	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	6.63	13.25	3.21	2.99	1.92	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	2.32	7.54	8.11	4.06	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	2.43	10.11	2.83	2.83	1.21	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1.63	14.64	5.29	3.25	1.63	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.15	7.25	5.96	0.81	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.03	6.31	5.56	0.90	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.44	6.59	6.15	1.32	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.31	6.29	4.02	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	10.05	4.37	2.18	0.66	0.87	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	10.97	5.91	2.95	0.84	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	8.00	6.93	4.80	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	12.34	4.66	4.21	0.75	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.90	6.55	4.54	1.47	0.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	11.74	6.21	5.01	0.86	0.17	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.31	4.91	3.36	0.13	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.46	6.79	3.64	0.49	1.21	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	7.74	5.93	5.42	0.52	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.08	4.75	4.43	1.90	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	8.24	3.85	0.00	0.55	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.55	7.07	3.54	0.94	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	9.21	6.62	5.01	0.97	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.59	7.96	5.79	0.54	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.12	6.28	3.77	1.05	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.55	7.42	3.32	0.39	0.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.55	8.23	2.95	0.42	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.41	7.26	3.13	0.66	0.99	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.54	6.73	3.93	0.37	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.35	6.52	3.64	0.57	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	11.24	7.15	4.50	1.02	0.61	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.48	6.65	2.01	0.60	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.42	5.40	2.97	1.08	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	7.20	10.56	3.36	1.44	0.24	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.65	7.29	4.47	0.71	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	10.83	7.17	3.66	0.44	0.88	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.97	10.33	2.74	0.63	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	12.41	7.52	3.15	0.87	0.87	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.64	6.42	2.81	0.80	1.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	12.33	7.44	3.49	1.86	0.47	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.56	8.16	3.36	0.00	1.20	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	10.73	5.36	1.79	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.38	8.14	2.87	0.72	0.96	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	12.13	8.29	2.02	1.01	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.25	9.63	0.82	0.82	0.41	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.90	12.90	2.89	0.44	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.36	11.71	1.42	0.71	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.26	12.26	1.66	0.00	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	6.71	5.87	0.00	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.18	4.13	0.92	0.92	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.32	6.81	0.32	0.32	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	16.06	7.39	0.32	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	14.14	7.86	2.83	0.00	0.31	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.17	7.76	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.65	10.09	0.56	1.68	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	8.76	1.59	1.59	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.81	8.49	1.02	0.34	0.68	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.02	6.50	0.65	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.49	6.74	0.35	1.42	0.35	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	23.40	8.29	0.00	0.98	0.98	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.78	7.44	0.50	0.99	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	24.39	8.44	0.94	0.00	0.94	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	20.20	6.29	2.32	1.99	0.33	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	29.39	6.50	1.24	1.86	0.93	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.05	5.50	2.45	1.53	1.22	0.61
Adipocyte - breast, donor1	11376-118A8	31.99	22.65	1.58	2.06	1.27	1.43
Adipocyte - breast, donor2	11327-117E4	25.67	21.02	4.49	1.44	1.28	0.80
Adipocyte - omental, donor1	11473-119C6	26.21	17.30	2.80	2.16	1.02	1.02
Adipocyte - omental, donor2	11474-119C7	20.18	14.95	1.49	3.74	2.99	0.00
Adipocyte - omental, donor3	11475-119C8	13.06	12.39	2.68	0.33	1.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	15.31	8.93	1.28	3.19	0.64	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	18.69	11.00	2.20	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.06	18.97	2.71	1.81	3.61	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	18.07	13.38	8.34	0.52	1.74	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	21.51	7.43	3.91	1.37	0.39	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	11.84	6.69	2.06	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	17.56	14.22	4.18	0.84	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	14.11	8.23	1.76	0.00	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	14.40	17.78	3.06	0.64	0.88	1.13
Adipocyte differentiation, day08, donor2	13023-139D8	10.01	8.07	4.20	0.97	0.32	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	13.33	1.60	0.00	2.13	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	10.02	13.35	1.67	1.11	0.56	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	10.81	28.28	4.99	1.66	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	11.80	11.30	2.51	0.25	0.75	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.47	18.65	4.25	0.33	0.98	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	8.83	18.57	4.26	0.61	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	19.45	15.47	4.86	5.52	1.55	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	13.63	15.78	2.51	5.74	1.79	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	8.39	3.59	2.40	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	16.55	8.82	2.52	3.60	0.36	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	20.08	8.37	11.71	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	19.72	6.57	4.11	4.93	0.82	0.62
Anulus Pulposus Cell, donor1	11248-116E6	28.95	12.82	5.15	1.03	0.69	0.80
Anulus Pulposus Cell, donor2	11463-119B5	19.35	13.22	4.90	1.96	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	14.83	3.15	4.04	0.00	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	14.76	17.80	1.74	2.60	0.87	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	8.56	2.14	8.56	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.94	13.75	1.20	1.49	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	16.44	6.32	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.86	13.86	2.64	1.32	1.32	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.07	15.59	2.92	1.95	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	17.96	15.53	3.40	4.37	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	13.66	13.66	1.78	1.78	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.20	15.44	1.88	3.77	1.13	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.96	18.14	3.63	1.45	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	12.54	1.25	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	18.45	13.01	2.14	2.47	0.49	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	12.28	5.46	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.57	12.97	4.37	1.96	1.81	1.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	13.39	3.75	2.68	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.36	11.34	3.40	1.51	0.94	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	14.43	11.23	2.14	0.80	1.07	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	14.63	16.58	1.95	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.77	13.10	1.66	1.49	1.16	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	12.01	2.40	2.40	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	21.24	0.00	7.08	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.95	13.04	2.92	2.57	1.03	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	16.78	0.00	4.19	4.19	12.58
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	17.96	20.87	1.46	0.49	0.49	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.56	17.45	1.90	1.90	1.14	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	13.33	1.21	0.00	2.42	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	16.53	12.54	4.56	2.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.46	14.11	4.92	1.92	0.21	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	16.26	11.87	4.13	1.55	1.29	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	12.20	13.14	5.63	3.28	2.35	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.47	12.54	2.57	2.25	1.61	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	8.56	3.57	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.62	12.28	2.92	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.04	15.96	3.31	1.20	0.90	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	14.26	2.38	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	18.82	13.22	3.56	1.53	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.24	12.48	3.57	2.29	0.51	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.98	19.06	3.81	0.64	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.15	10.79	3.02	1.29	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.36	11.64	2.75	1.27	2.12	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.44	11.02	3.19	1.45	0.58	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	11.34	18.89	5.67	3.78	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	16.95	14.58	3.05	2.03	1.19	0.68
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	6.95	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	6.34	14.79	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	17.58	14.58	3.65	1.72	1.29	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.25	13.84	1.80	4.21	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	16.04	18.95	2.19	2.92	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	15.86	14.25	4.60	2.53	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	17.85	0.00	2.55	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	20.85	17.03	5.59	1.53	1.27	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	20.02	13.42	2.48	1.86	0.83	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.69	12.24	3.06	1.53	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	22.94	13.86	3.82	2.87	1.91	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	15.74	13.30	2.66	2.00	1.55	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	7.63	4.58	3.05	0.00	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.28	11.63	0.55	2.22	2.22	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	15.09	12.97	4.50	2.12	1.59	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.72	15.26	0.73	1.82	1.45	0.73
Astrocyte - cerebellum, donor1	11500-119F6	27.63	17.93	3.93	2.70	0.98	1.47
Astrocyte - cerebellum, donor2	11580-120F5	26.70	24.65	5.13	3.77	2.40	1.37
Astrocyte - cerebellum, donor3	11661-122F5	22.65	15.73	3.15	0.84	0.63	0.84
Astrocyte - cerebral cortex, donor1	11235-116D2	15.69	11.15	2.44	0.00	2.44	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	15.37	12.13	2.75	0.65	1.46	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	15.51	15.51	3.13	0.30	1.19	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	10.21	6.88	6.77	1.95	0.57	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	12.65	11.02	6.51	1.75	0.75	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	8.42	7.62	4.67	1.37	0.46	0.23
Basophils, donor1	12241-129G9	4.71	9.15	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	4.69	7.58	0.00	0.72	0.00	0.36
Basophils, donor3	12243-129H2	6.76	9.26	0.29	0.29	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	19.84	5.39	5.61	4.10	0.22	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	15.09	6.86	5.03	5.03	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	10.04	3.77	6.90	3.14	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.65	6.03	7.69	4.99	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	10.13	2.99	4.61	1.61	0.23	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	13.14	3.96	6.48	4.14	0.18	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	12.47	5.77	7.52	12.68	0.52	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	13.28	4.89	9.08	6.06	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	22.06	4.80	2.24	2.56	0.32	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	5.07	10.14	0.00	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	4.27	7.80	0.19	0.19	0.19	0.19
CD14+ Monocytes, donor3	11381-118B4	4.83	10.10	0.22	0.22	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	18.96	18.11	3.96	1.13	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	15.54	11.37	3.03	1.14	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	20.05	18.74	0.33	1.64	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	8.24	12.86	0.14	0.72	0.58	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	3.32	7.54	0.30	0.60	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	8.05	9.71	0.00	0.95	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.52	11.72	0.17	0.17	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.07	9.66	0.00	0.28	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1.74	11.65	0.00	0.74	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.33	10.96	0.20	0.20	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.85	8.90	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.22	11.53	0.00	0.22	0.65	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.87	11.00	0.00	0.23	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	2.11	10.56	0.00	0.00	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	16.64	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.06	10.86	0.15	0.45	0.00	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	3.79	8.18	0.40	0.20	0.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.37	10.62	0.21	0.42	0.42	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	3.89	8.24	0.00	0.46	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	3.17	8.14	0.23	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.31	9.60	0.00	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.65	8.88	0.27	0.27	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.49	8.72	0.00	0.35	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.73	9.26	0.00	0.42	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	1.84	9.92	0.00	0.37	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.35	10.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.51	12.28	0.00	0.00	1.32	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	3.49	7.85	0.17	0.35	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3.72	11.15	0.00	0.74	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	3.45	14.23	0.22	0.22	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	2.46	8.19	0.41	0.00	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.32	5.56	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.78	12.53	0.00	0.46	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	14.39	14.60	0.22	1.31	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	12.94	19.63	0.46	0.92	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	11.91	14.51	1.08	0.22	0.22	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	23.83	14.48	0.16	0.93	0.47	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	16.77	15.54	1.40	0.52	0.70	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	15.16	15.61	0.67	0.22	0.67	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	13.52	22.46	0.51	0.26	0.51	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	13.39	20.20	0.66	0.22	0.00	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	12.00	19.16	0.42	0.00	0.63	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	4.06	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.95	2.71	1.36	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	12.43	4.14	0.00	1.04	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	16.52	6.93	1.07	2.13	1.07	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	23.05	3.75	1.07	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	25.27	2.11	0.70	1.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.04	4.71	0.00	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	3.95	6.59	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	9.04	2.47	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	4.35	2.90	0.00	0.73	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	4.04	3.03	0.50	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	7.68	37.98	2.83	2.42	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	5.99	31.16	1.20	0.00	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	10.04	2.01	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2.81	3.37	1.12	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.54	4.13	2.63	1.13	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	16.91	6.09	2.93	1.13	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	4.64	2.14	0.71	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	5.51	1.22	2.45	1.22	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	6.40	3.05	1.83	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.42	1.79	1.79	2.04	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	20.66	3.59	2.02	2.47	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	17.54	1.44	2.59	1.44	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	16.59	1.42	2.37	1.42	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	18.26	4.92	0.70	3.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	0.00	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	15.32	3.61	1.16	1.30	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	11.86	2.71	1.69	2.03	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	15.15	2.26	2.58	0.81	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.90	2.69	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	14.32	3.49	0.35	1.05	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.96	3.96	0.88	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	17.71	2.95	1.69	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	15.58	2.49	0.42	2.08	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	8.69	3.01	2.34	0.67	0.33	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	17.13	3.54	2.72	2.99	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	16.08	6.43	0.54	2.14	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	23.31	3.59	0.00	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.91	3.71	1.67	1.48	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	12.13	3.68	1.52	1.52	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	13.24	4.62	2.10	0.84	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.68	3.03	1.01	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	13.43	0.87	0.87	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	17.87	3.92	3.05	0.87	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	26.72	4.95	1.98	1.98	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	1.85	0.00	1.85	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	40.48	2.79	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	19.94	6.65	2.22	1.94	0.83	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	19.14	6.13	1.96	0.98	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	27.72	3.08	1.54	6.16	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	23.99	7.52	1.79	2.51	0.36	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	30.47	4.15	1.38	0.00	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	5.89	3.27	0.65	0.65	0.65	0.33
CD8+ T Cells, donor2	11307-117C2	7.13	6.38	0.75	0.75	0.00	0.75
CD8+ T Cells, donor3	11383-118B6	10.86	2.27	1.01	1.01	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	4.82	3.67	3.44	0.92	1.15	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	4.31	3.12	1.20	2.40	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	3.56	4.10	3.01	1.37	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.30	3.90	1.80	2.10	1.50	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	3.12	3.36	1.20	1.92	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	4.78	3.41	0.68	1.59	0.45	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	4.13	3.48	2.61	1.96	0.87	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	5.53	3.95	4.21	1.58	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.92	2.35	1.88	0.94	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.43	3.92	4.83	1.21	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.10	2.61	1.74	1.16	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.13	3.46	1.87	0.80	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2.63	3.06	4.82	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	2.73	0.00	1.37	1.37	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	3.73	0.00	1.49	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	4.32	3.60	1.44	1.08	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	5.47	4.89	2.01	0.86	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	4.24	3.06	1.18	1.18	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	5.07	3.49	2.54	2.22	0.63	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	3.08	1.54	2.46	2.15	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	2.24	1.60	2.89	0.32	0.96	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	4.59	1.15	2.29	1.91	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.94	1.97	2.36	1.18	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.76	3.03	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	3.21	3.21	4.82	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	0.70	1.40	8.39	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2.00	3.01	6.01	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	12.79	12.79	0.00	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	16.80	13.34	2.96	1.48	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	23.99	10.42	2.53	2.21	1.05	0.84
Chondrocyte - de diff, donor1	11261-116G1	27.39	16.64	4.16	2.08	2.43	1.73
Chondrocyte - de diff, donor2	11338-117F6	22.03	15.64	4.62	1.42	2.13	0.71
Chondrocyte - de diff, donor3	11410-118E6	28.56	16.73	5.69	2.50	0.91	0.80
Chondrocyte - re diff, donor2	11339-117F7	26.86	8.06	3.58	3.58	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	25.48	8.49	2.83	0.81	1.62	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	20.66	15.26	3.10	0.92	0.46	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	17.53	8.34	2.57	1.28	2.14	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	19.03	10.71	2.83	1.50	0.97	1.24
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	26.78	25.58	3.76	1.47	1.38	1.74
Corneal Epithelial Cells, donor1	11526-119I5	20.86	7.90	8.12	4.61	0.88	0.22
Corneal Epithelial Cells, donor2	11606-120I4	14.79	9.10	9.10	4.55	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.10	8.69	9.71	7.41	1.02	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	12.22	11.23	1.49	1.65	0.83	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	13.88	14.82	0.95	0.63	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	20.70	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	15.66	10.26	2.48	0.65	0.97	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	9.22	12.30	1.37	1.71	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	7.18	6.53	3.26	0.65	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	6.78	9.68	1.45	0.00	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	14.51	4.34	0.83	1.83	2.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	3.52	1.76	0.59	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	13.86	5.37	1.70	1.41	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	12.19	2.75	0.79	1.18	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	15.13	6.69	0.58	0.29	1.16	0.00
Endothelial Cells - Artery, donor2	11341-117F9	13.88	6.35	1.65	1.18	0.71	1.18
Endothelial Cells - Artery, donor3	11413-118E9	16.30	5.61	2.28	1.23	0.00	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	15.96	1.77	2.22	1.99	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.82	2.13	2.13	1.22	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	12.97	2.54	1.13	1.41	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	14.26	2.38	1.19	2.38	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	14.58	2.60	1.04	1.56	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	22.12	2.27	0.71	2.69	0.57	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	15.20	4.40	3.20	0.40	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	20.96	5.77	0.52	3.14	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	24.23	5.72	1.37	2.98	0.87	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	10.86	2.39	1.74	1.09	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	14.29	3.30	2.08	1.22	0.37	0.37
Endothelial Cells - Vein, donor1	11267-116G7	14.79	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	2.79	0.00	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.58	3.93	1.57	1.88	0.16	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	6.60	0.00	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	3.57	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	15.15	5.13	3.66	5.13	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	8.32	8.32	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.65	11.90	2.87	2.46	0.82	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	18.61	18.72	4.93	3.83	1.53	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.95	16.25	4.33	1.84	1.84	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	32.87	13.34	3.64	3.88	0.97	2.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	22.93	20.88	7.23	5.73	1.77	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	22.99	16.98	5.59	2.74	0.84	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	12.12	13.70	3.69	3.16	0.53	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.24	16.94	2.99	1.33	0.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	19.05	12.25	4.54	2.72	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	10.61	10.61	0.00	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	25.71	10.09	3.79	3.47	1.58	1.26
Fibroblast - Cardiac, donor4	11452-119A3	21.22	10.91	5.46	1.52	1.21	1.82
Fibroblast - Cardiac, donor5	11456-119A7	15.23	7.36	3.43	1.90	0.51	0.63
Fibroblast - Cardiac, donor6	11460-119B2	16.68	11.22	3.49	1.97	0.61	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	21.17	18.09	5.90	2.28	1.34	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	17.26	10.79	2.59	0.86	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	10.25	4.39	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	32.52	32.98	13.15	2.08	1.85	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	23.07	14.25	4.75	1.87	0.85	0.17
Fibroblast - Dermal, donor1	11269-116G9	24.65	10.80	7.04	2.11	2.35	1.17
Fibroblast - Dermal, donor2	11346-117G5	25.94	16.04	8.49	3.30	2.36	4.25
Fibroblast - Dermal, donor3	11418-118F5	34.57	13.78	6.65	1.45	2.30	1.33
Fibroblast - Dermal, donor4	11450-119A1	17.97	12.55	5.20	0.90	1.70	0.68
Fibroblast - Dermal, donor5	11454-119A5	20.76	12.74	5.76	1.40	1.05	1.40
Fibroblast - Dermal, donor6	11458-119A9	20.95	12.99	7.31	1.79	0.97	0.49
Fibroblast - Gingival, donor1	11237-116D4	23.95	15.20	5.41	1.87	1.25	2.29
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	18.34	20.44	6.29	0.52	0.79	1.05
Fibroblast - Gingival, donor2	11318-117D4	20.03	14.89	5.40	1.58	0.40	1.32
Fibroblast - Gingival, donor3	11394-118C8	23.69	11.41	6.67	0.48	1.45	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	23.89	6.23	3.12	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.62	11.98	2.11	1.23	0.53	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	19.95	23.38	4.83	1.71	1.56	2.18
Fibroblast - Gingival, donor6 (control)	11922-125H5	22.18	20.15	5.68	1.62	1.49	1.89
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	23.29	18.70	2.82	1.41	2.47	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	21.06	25.59	5.85	2.05	0.73	2.05
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.64	22.50	7.09	0.95	0.95	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	17.22	23.04	4.50	1.10	1.43	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	20.25	12.62	4.11	0.73	0.59	1.03
Fibroblast - Lung, donor1	11270-116H1	10.87	9.52	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	11.94	14.92	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	24.27	10.97	2.95	0.84	1.69	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	39.15	34.15	3.33	5.00	2.50	5.00
Fibroblast - Lymphatic, donor2	11586-120G2	26.57	4.20	4.20	1.40	1.40	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	27.43	19.31	3.08	2.24	1.12	1.12
Fibroblast - Mammary, donor1	11540-120B1	46.69	30.85	10.56	2.03	2.44	3.65
Fibroblast - Mammary, donor2	11620-122A9	19.97	19.97	0.00	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	17.87	0.00	5.96	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	22.31	16.49	6.79	1.36	0.19	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	20.33	12.74	5.01	1.52	0.91	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	25.70	14.99	5.51	2.14	0.61	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	21.37	9.54	3.05	0.76	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	22.68	20.52	3.51	0.81	1.62	2.43
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.18	15.66	3.13	1.28	0.81	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.08	15.03	4.31	3.87	1.33	1.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	25.40	33.93	4.27	2.44	1.22	2.44
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.06	22.72	4.68	2.67	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	22.93	13.05	7.91	1.19	0.79	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	13.30	20.84	2.98	1.59	1.59	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	25.04	15.28	2.66	1.24	1.42	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.48	14.98	3.74	1.97	0.99	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	16.85	12.03	4.21	1.50	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	20.62	19.97	4.10	1.62	1.51	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	17.97	22.27	3.54	0.76	2.53	0.00
Fibroblast - skin normal, donor1	11553-120C5	24.94	19.53	3.94	1.48	0.82	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	15.64	13.43	8.02	1.00	1.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	19.19	17.68	3.72	2.91	1.31	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.53	16.32	3.32	1.21	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	26.84	16.82	2.49	1.57	1.16	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	30.43	18.46	4.62	0.85	0.85	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.08	15.44	4.60	0.66	0.99	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.58	25.14	3.83	2.56	1.38	1.38
Fibroblast - skin walker warburg, donor1	11554-120C6	20.07	15.35	5.40	1.52	1.69	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	19.60	17.56	4.70	1.10	1.25	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	44.32	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	21.79	11.33	0.87	0.87	1.74	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	11.27	5.89	3.47	2.77	0.35	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	8.85	5.99	4.42	5.73	0.52	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	10.48	4.09	3.58	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	14.55	7.66	3.83	1.53	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.76	12.12	1.91	1.91	1.28	5.10
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	13.98	19.97	7.99	0.29	0.86	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	7.45	4.96	4.69	1.10	1.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	8.68	5.94	2.51	0.46	0.23	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	14.46	14.86	7.93	2.18	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	7.93	5.02	4.76	1.32	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	7.50	3.91	4.57	0.33	0.98	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	16.36	19.90	4.86	2.65	0.44	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.70	8.48	9.75	2.97	1.41	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	10.59	8.74	6.03	2.34	1.11	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	9.13	6.72	9.94	3.76	1.34	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.50	8.18	5.82	1.24	1.61	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	13.70	9.27	7.61	2.08	2.21	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.42	8.54	6.30	1.63	0.81	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	10.50	5.93	5.25	2.28	0.46	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	11.71	6.98	4.36	2.24	0.75	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	11.58	6.99	5.03	1.53	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	12.71	6.50	4.43	2.36	1.18	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	13.67	7.79	6.04	1.11	0.32	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	17.87	6.48	6.26	1.12	1.56	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	13.71	7.06	6.86	0.81	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	16.12	8.14	5.09	2.54	1.02	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	12.50	6.38	5.85	2.84	0.98	1.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.54	10.51	4.99	1.98	1.14	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.08	12.30	3.59	2.05	1.54	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.82	9.29	5.09	1.00	1.55	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.73	8.07	5.16	2.00	1.00	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	14.91	8.37	4.90	2.45	1.63	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	13.00	6.19	5.78	1.44	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	13.95	8.19	4.15	2.19	1.15	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	13.01	10.17	7.34	2.00	1.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.45	7.27	4.63	0.66	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	21.03	13.65	7.01	1.60	1.48	0.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	12.97	7.29	4.05	1.62	0.81	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	10.26	8.02	5.45	0.64	1.28	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.96	9.19	5.50	1.71	0.95	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.24	9.97	8.23	0.79	0.95	1.11
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	10.64	8.51	4.26	0.91	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	15.47	9.09	5.02	1.05	1.15	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	15.37	7.03	5.49	1.10	1.54	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	11.78	8.42	6.73	1.40	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	13.24	11.67	5.00	1.94	1.02	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	14.71	13.90	6.69	2.14	1.07	1.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	11.63	8.11	3.83	2.60	0.92	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	17.23	11.27	5.31	2.07	1.42	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.69	11.93	5.42	1.63	1.63	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.93	7.37	2.21	0.55	0.55	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	16.89	11.84	3.73	1.10	1.75	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	10.91	2.98	2.98	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.85	8.18	3.17	1.32	1.06	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	15.54	8.27	3.03	0.40	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	35.58	11.69	8.90	3.56	1.02	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	8.56	12.14	5.37	1.59	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	11.25	6.32	8.01	1.54	0.46	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	9.00	6.96	6.34	2.25	0.61	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	10.33	5.95	7.51	2.50	1.25	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.06	8.19	5.09	2.54	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	7.38	5.53	3.69	2.31	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	9.90	7.42	2.47	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.51	10.06	7.35	1.16	1.16	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3.21	14.44	17.65	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	3.48	1.74	1.74	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.21	8.14	4.23	0.98	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	7.41	4.94	4.94	1.65	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	0.00	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	5.87	4.19	4.19	0.84	1.12	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.17	7.84	2.94	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.07	3.36	1.68	1.68	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	6.68	4.13	7.00	1.59	0.32	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.11	6.45	2.72	1.02	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	6.26	6.26	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.31	8.02	5.73	2.29	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	9.47	5.92	3.55	0.59	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	3.39	5.08	3.39	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	10.36	5.80	2.90	1.66	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	8.05	4.60	5.75	1.38	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	0.00	5.27	10.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	4.61	4.61	4.23	1.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	5.87	4.56	2.28	0.98	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	1.34	2.01	0.67	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	9.63	6.16	3.47	1.16	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	7.53	5.48	4.79	1.71	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	7.45	4.97	0.00	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	10.38	4.25	7.08	0.47	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	9.05	4.83	4.22	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	7.63	6.61	3.56	0.51	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	12.36	3.59	3.59	1.99	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	10.85	3.45	6.91	1.97	0.49	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	12.98	2.36	7.08	3.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.84	5.83	2.33	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	7.46	5.27	2.19	2.63	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	7.63	3.39	9.32	0.00	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	6.57	4.78	4.18	0.60	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.19	4.85	2.91	1.46	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	19.40	2.28	0.00	3.42	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	16.22	22.45	2.08	1.25	2.49	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	21.36	5.62	1.12	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.32	14.59	3.49	1.27	2.22	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	31.75	20.89	4.60	3.76	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	15.67	22.98	9.05	4.53	1.04	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	18.91	26.00	10.47	4.73	2.36	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.61	24.57	7.96	4.32	2.28	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	20.99	24.16	9.84	4.26	1.20	2.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	19.99	25.36	9.03	3.65	2.15	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	14.85	23.25	9.04	2.80	2.15	1.29
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	16.81	23.66	8.47	4.73	1.62	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	16.81	22.13	7.89	3.95	1.20	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	14.42	21.14	9.29	4.16	1.60	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.99	3.36	1.12	2.80	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.91	19.91	2.60	2.16	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	5.29	0.00	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	28.57	18.69	5.64	3.53	2.47	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	14.53	5.09	3.63	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.81	10.32	4.20	1.75	1.22	0.70
Hepatocyte, donor1	11523-119I2	14.53	13.32	0.00	2.42	1.21	1.21
Hepatocyte, donor2	11603-120I1	11.85	15.08	1.08	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	16.57	22.70	3.68	0.61	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	3.26	15.66	1.31	0.00	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	10.14	4.02	16.43	7.52	0.52	1.40
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.29	10.02	3.98	1.92	1.10	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	6.68	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	1.38	4.15	0.00	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	2.56	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	9.14	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	3.25	3.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	0.00	1.67	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2.65	3.97	3.97	2.65	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	6.65	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.67	4.41	0.00	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	6.19	3.09	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	2.58	6.46	1.29	1.29	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	3.22	1.61	0.00	4.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	4.07	0.81	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	5.88	1.26	1.68	0.42	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	3.21	3.21	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	1.85	3.69	2.77	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	3.78	2.83	2.83	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	6.35	2.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	5.38	4.30	2.15	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	3.81	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.19	1.91	0.00	1.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	3.65	3.65	1.82	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.86	2.14	2.86	1.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	3.40	6.79	2.16	1.23	0.31	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	1.76	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	9.43	3.14	0.00	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.09	2.09	3.48	2.09	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	2.21	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	0.00	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	1.74	2.62	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	2.13	4.27	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	2.77	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	5.52	3.68	2.76	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	1.06	5.29	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	11.42	4.49	4.57	4.08	0.41	1.14
Keratinocyte - epidermal, donor2	11349-117G8	4.69	3.51	5.27	2.34	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	13.25	6.91	6.34	3.12	0.76	0.66
Keratinocyte - oral, donor1	11251-116E9	20.55	6.58	7.15	4.65	0.68	0.23
Keratocytes, donor1	11527-119I6	21.32	28.19	23.04	1.38	2.41	2.75
Keratocytes, donor2	11607-120I5	26.95	22.26	10.55	4.69	0.00	0.00
Keratocytes, donor3	11688-122I5	14.42	8.30	12.25	0.00	0.40	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	15.39	0.00	4.40	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	16.18	4.31	2.16	0.00	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	18.45	10.84	4.27	1.96	0.58	1.15
Lens Epithelial Cells, donor3	11690-122I7	24.32	6.86	2.12	3.94	0.81	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	18.74	4.39	1.19	2.85	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.88	5.58	0.56	2.51	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	21.09	3.78	1.26	3.31	0.79	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	20.97	1.61	0.54	1.61	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.09	3.15	1.58	1.58	0.63	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	17.36	2.80	1.40	2.26	0.32	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	17.24	4.51	1.23	2.05	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	19.47	3.29	1.26	0.25	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	15.76	3.38	1.41	3.10	0.14	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	17.40	3.96	2.37	1.58	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.35	2.71	0.78	2.13	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	17.59	4.44	1.30	1.30	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	16.03	2.09	1.74	2.79	0.70	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.98	2.15	2.15	1.67	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.34	3.71	0.82	1.79	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	14.78	3.70	1.23	2.16	0.92	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.03	2.81	0.62	0.94	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.49	2.74	1.46	2.56	0.73	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.10	3.29	0.99	0.99	0.99	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.47	3.22	1.17	2.05	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.42	2.49	1.74	2.99	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	18.91	2.91	0.97	1.45	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	15.89	2.96	1.08	1.89	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.14	3.48	1.21	1.82	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.00	2.59	1.56	4.15	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.91	1.88	0.63	1.88	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	17.29	3.01	0.75	1.20	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	4.13	2.75	2.75	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	13.73	1.88	0.94	0.94	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	18.77	2.86	0.85	1.70	0.53	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.99	5.81	0.97	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.93	2.32	0.33	1.65	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	15.61	2.35	0.62	2.11	0.37	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	18.51	2.96	1.11	1.85	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.61	1.98	1.48	0.49	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.77	2.47	0.96	1.37	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	14.80	4.82	1.29	2.25	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.04	1.83	2.43	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.08	4.76	1.26	1.82	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.78	3.20	0.71	1.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.60	5.33	0.48	2.91	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	18.98	2.80	1.09	1.24	0.78	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.91	3.58	1.43	1.43	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.76	2.61	1.63	0.98	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	18.36	2.12	1.88	1.65	0.71	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	16.95	3.34	1.98	2.23	0.87	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.78	2.82	0.77	0.51	0.26	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	15.51	1.79	1.19	0.30	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	15.34	8.44	3.07	2.30	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	6.68	11.13	3.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.16	5.50	1.69	1.27	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	9.14	3.52	2.81	0.70	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	8.41	3.74	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	4.64	2.58	1.03	2.06	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	4.76	2.38	4.76	3.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	4.98	6.11	2.71	2.04	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	8.72	4.65	2.62	1.16	1.45	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.55	6.30	1.80	1.80	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.21	7.45	2.44	2.98	0.14	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	6.16	5.65	3.59	0.00	1.03	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.88	4.94	3.88	1.41	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	11.33	6.00	2.00	2.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	7.13	6.11	3.06	2.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.54	5.07	3.47	0.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	11.90	8.31	3.40	2.27	0.19	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.14	5.52	4.29	0.61	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	7.34	4.08	4.89	3.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	11.45	6.87	3.54	0.83	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	9.53	3.92	4.20	1.96	0.00	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	3.09	6.18	2.06	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	11.03	7.55	3.48	2.03	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	7.47	4.78	4.78	2.69	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	8.85	5.53	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.72	4.60	1.77	2.47	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.38	7.01	3.69	3.32	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	3.45	4.61	8.06	2.30	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.44	3.84	6.91	1.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	5.66	2.26	2.26	1.70	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.13	4.10	3.28	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.42	4.97	5.87	1.36	1.36	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	9.34	3.59	1.44	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	9.71	4.48	7.47	0.75	2.99	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	5.57	6.32	2.97	2.60	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.46	6.89	4.74	1.72	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	7.71	2.57	4.28	5.14	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.66	7.33	4.66	2.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.64	5.43	4.22	1.81	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	7.82	2.84	2.13	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.62	5.50	3.44	0.69	0.34	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	4.83	5.37	1.61	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	8.75	2.02	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.26	3.33	4.07	1.85	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	5.81	1.16	6.98	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	6.35	4.23	1.06	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.40	8.00	2.40	2.80	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	5.09	5.09	1.45	0.00	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	3.83	3.07	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	7.89	4.44	4.93	2.96	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	8.47	2.82	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	6.54	8.05	4.02	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.81	5.86	5.86	2.70	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	6.88	3.44	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.02	8.02	3.56	2.23	0.89	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.17	6.26	5.47	1.56	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.24	5.28	4.62	1.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7.78	8.82	3.63	1.04	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	8.31	8.75	2.19	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.27	5.59	5.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	12.37	9.27	2.21	2.65	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	8.10	8.49	1.93	1.93	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	8.61	10.13	2.53	2.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7.69	6.73	2.40	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.34	6.76	4.37	1.59	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	10.33	7.90	6.68	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	3.46	4.84	2.77	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	10.26	6.08	4.18	1.52	0.00	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.68	4.13	3.61	1.55	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	5.44	3.02	2.42	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	9.51	6.97	3.80	0.00	0.95	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	4.80	8.53	2.67	4.26	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.60	6.90	5.75	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	6.17	6.17	2.57	2.57	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	5.66	7.07	2.83	2.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	8.51	9.65	2.84	2.27	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	10.40	8.32	2.91	1.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9.40	6.26	5.48	3.92	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	11.27	6.26	4.18	0.84	1.67	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.90	6.04	3.72	3.25	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.03	6.02	4.01	2.01	0.67	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.09	5.88	3.74	2.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	11.31	4.45	4.85	2.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	5.51	4.59	8.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	6.22	2.67	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	12.54	7.98	6.84	0.57	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	6.14	3.07	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.02	2.74	6.57	2.74	0.00	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	6.68	3.56	4.01	1.78	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	7.28	4.68	5.46	2.08	0.00	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	3.98	3.32	2.65	5.30	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	6.24	8.31	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	19.37	14.13	2.96	1.14	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	15.97	14.68	3.12	1.28	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	18.09	15.86	3.15	0.52	0.52	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	4.25	10.09	3.19	2.66	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	8.56	7.76	5.39	4.91	0.00	0.95
Mallassez-derived cells, donor3	11930-125I4	9.45	7.78	4.73	3.61	0.83	0.14
Mammary Epithelial Cell, donor1	11273-116H4	17.94	6.88	8.47	8.17	0.60	0.60
Mammary Epithelial Cell, donor2	11350-117G9	21.43	8.98	7.82	7.82	0.87	0.87
Mammary Epithelial Cell, donor3	11422-118F9	9.48	5.74	5.99	3.99	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	6.10	4.07	0.68	0.68	0.68	0.00
Mast cell, donor1	11563-120D6	22.71	5.30	2.05	1.19	1.30	0.76
Mast cell, donor2	11565-120D8	20.51	2.08	0.89	0.89	0.59	0.59
Mast cell, donor3	11566-120D9	22.06	4.73	0.23	0.68	0.90	0.00
Mast cell, donor4	11567-120E1	20.39	3.01	0.71	0.00	0.71	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	23.95	5.43	3.77	1.66	0.67	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	16.93	4.09	0.00	1.75	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	23.29	7.80	2.52	1.49	0.92	0.57
Mast cell, expanded, donor8	11941-126A6	19.25	3.51	0.84	1.17	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	24.77	2.98	2.29	3.48	0.50	0.20
Melanocyte - dark, donor2	11582-120F7	16.61	9.69	2.08	2.08	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	42.60	25.93	11.81	3.84	1.74	2.68
Melanocyte - light, donor1	11274-116H5	12.46	19.75	7.05	1.88	1.41	0.71
Melanocyte - light, donor2	11351-117H1	16.38	18.43	6.14	0.68	2.05	0.00
Melanocyte - light, donor3	11423-118G1	13.88	13.01	6.94	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	31.55	28.32	8.12	2.50	1.87	2.29
Melanocyte, donor2 (MC+2)	12739-135I3	21.52	18.29	4.03	2.69	0.54	1.88
Melanocyte, donor3 (MC+3)	12837-137B2	25.18	20.89	9.64	2.68	1.34	1.34
Meningeal Cells, donor1	11493-119E8	29.40	24.07	3.47	3.47	2.48	1.74
Meningeal Cells, donor2	11573-120E7	21.13	14.08	3.96	2.20	3.08	0.88
Meningeal Cells, donor3	11654-122E7	25.35	19.64	3.99	2.12	1.55	1.87
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	32.79	16.25	3.14	1.43	2.28	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.30	11.07	2.11	2.21	0.60	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	15.77	5.26	1.31	2.63	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	35.32	28.78	1.31	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	25.83	21.53	5.02	2.15	2.87	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.76	22.02	2.75	1.06	1.06	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.59	20.61	1.01	2.01	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	35.38	25.05	5.93	4.40	2.42	2.42
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	36.53	32.15	6.58	5.11	0.00	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	33.15	21.28	5.12	5.32	2.25	1.84
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	24.93	14.82	9.42	2.08	0.83	1.11
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	27.88	21.19	2.97	2.23	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.66	16.45	2.63	1.58	0.79	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.73	9.50	4.15	0.89	0.30	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	9.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	17.93	9.61	5.12	4.48	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	35.80	25.87	2.48	2.48	2.48	2.84
Mesenchymal stem cells - hepatic, donor0	11218-116B3	21.27	12.82	5.94	1.88	0.94	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	23.95	13.79	5.08	2.18	2.18	3.63
Mesothelial Cells, donor1	11247-116E5	22.01	12.73	4.77	4.77	2.39	1.59
Mesothelial Cells, donor2	12156-128G5	21.02	14.51	3.50	4.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	18.21	14.09	2.17	1.16	1.52	0.79
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	4.05	14.85	4.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	8.62	14.04	2.46	0.99	0.99	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	12.96	14.13	1.47	0.29	0.29	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	6.91	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.71	11.47	3.10	0.62	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.62	10.58	1.24	0.41	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.76	9.51	2.25	0.75	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.52	13.03	1.86	0.00	0.93	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	13.01	10.97	2.03	0.81	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.46	12.27	1.98	0.40	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	6.19	13.27	5.31	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.58	14.82	1.52	2.28	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	5.26	0.00	0.00	0.00	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.22	7.22	1.70	0.64	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	11.05	1.84	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.84	9.84	2.09	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	6.71	3.35	0.00	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.03	11.04	1.51	1.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.37	8.79	1.19	0.48	0.48	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.21	4.98	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.53	10.13	0.92	0.23	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	9.68	7.36	1.05	0.42	1.26	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	6.32	6.32	1.02	0.82	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	6.87	8.58	1.07	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.67	7.78	1.11	1.33	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	4.82	6.57	2.41	0.22	0.44	0.88
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.55	5.58	0.00	0.00	1.01	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	0.00	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.16	5.98	0.54	0.82	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	5.59	6.76	0.29	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	8.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	8.65	0.96	0.96	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.60	9.61	0.40	0.00	0.80	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	8.23	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	11.51	1.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	8.15	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.82	15.33	0.88	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	5.52	2.21	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	4.48	4.48	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.41	14.13	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.87	10.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	15.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.57	16.07	2.05	2.05	1.71	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.13	6.13	0.88	0.88	1.31	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.62	8.52	0.71	0.71	1.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.78	17.11	1.96	1.40	1.12	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	4.16	9.98	0.83	0.42	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	8.16	0.58	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.84	13.57	3.02	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.93	12.52	0.83	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	11.08	0.00	1.85	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	16.50	14.23	1.14	1.71	1.71	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	7.32	8.84	0.69	0.41	0.41	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	9.59	10.63	0.78	0.78	0.52	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.01	10.30	0.43	0.43	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.72	7.62	0.64	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	6.94	8.01	2.67	1.33	0.53	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.78	10.18	1.80	0.30	0.60	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.49	6.92	0.71	0.28	0.28	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.15	12.74	2.23	1.59	1.91	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.28	11.06	0.44	1.11	0.22	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	8.72	7.58	1.52	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.93	13.92	1.14	0.57	0.85	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	13.52	10.08	1.47	2.46	0.98	0.98
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.17	3.91	0.00	0.65	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.41	8.23	0.88	0.59	0.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.80	14.99	2.02	0.29	0.58	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	4.53	9.48	0.82	0.00	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.59	8.04	3.28	0.30	0.30	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	11.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	12.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.03	13.47	2.96	1.97	0.99	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	26.30	2.10	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	11.07	11.47	2.17	0.59	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	13.04	5.59	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	18.03	13.14	1.50	1.88	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.85	17.58	2.66	1.07	0.53	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.88	15.16	1.70	0.57	0.57	0.57
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	9.58	8.84	1.47	2.21	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.12	15.76	0.73	1.47	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	6.22	10.89	3.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	8.55	6.41	0.00	0.53	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	11.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	20.20	4.04	2.02	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.96	16.87	2.11	0.42	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	4.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	5.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	2.43	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	3.02	1.51	0.00	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	45.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	3.26	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	14.26	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	29.95	25.42	4.52	4.74	1.08	1.94
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.90	14.11	3.14	1.57	1.05	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.01	13.35	6.01	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	13.77	11.27	4.59	1.25	1.25	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	12.93	12.36	7.23	0.57	0.76	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	12.77	6.38	6.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.92	9.52	1.36	1.36	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	5.51	3.68	3.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	13.81	9.63	3.35	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.85	12.78	7.67	2.32	0.70	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.35	6.49	2.97	0.27	1.08	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.88	8.83	2.10	0.84	0.84	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.41	7.94	2.98	0.50	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	9.47	9.74	4.33	0.81	1.08	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	12.92	9.29	4.08	0.68	0.68	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.61	6.86	3.10	0.00	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.30	8.02	1.28	0.00	1.09	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	17.50	11.14	6.37	0.53	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	7.80	1.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.24	6.56	5.58	0.33	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.41	13.50	3.25	0.33	0.65	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.70	11.82	3.70	0.53	0.71	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	13.36	3.52	2.81	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.65	15.63	1.38	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.85	5.46	4.18	0.32	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	8.28	11.38	7.24	1.38	0.00	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	12.64	5.06	0.00	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.03	10.92	1.11	0.67	0.45	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.28	8.89	2.96	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.97	11.39	4.98	0.71	0.95	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.32	16.74	4.72	0.00	0.43	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	0.00	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	13.00	8.00	5.33	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	5.86	1.80	1.35	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	10.71	7.94	1.59	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	7.43	4.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	14.00	9.46	7.19	0.76	0.00	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.75	10.43	1.63	1.96	0.33	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.64	10.46	3.05	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	9.95	9.05	0.90	0.45	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	9.70	1.76	0.00	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.97	9.97	3.32	0.66	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	15.38	10.42	3.47	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.16	8.80	1.91	0.77	0.38	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	16.63	15.12	6.96	0.60	1.21	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.48	10.17	3.09	0.66	1.33	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.88	9.49	0.68	0.68	1.36	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	0.00	0.00	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.12	11.58	4.88	0.61	1.83	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.53	11.02	1.89	0.63	0.63	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	7.87	8.47	2.42	0.00	0.30	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.82	6.33	3.16	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	3.40	11.34	6.80	0.00	1.13	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	10.12	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	26.46	22.36	4.84	3.23	2.61	1.99
Myoblast, donor2	11322-117D8	22.25	20.90	4.22	4.22	0.77	0.96
Myoblast, donor3	11398-118D3	22.70	15.47	7.06	2.86	1.85	1.85
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.67	2.33	6.71	2.77	0.73	0.29
Natural Killer Cells, donor1	11230-116C6	6.46	7.69	0.92	0.62	0.31	0.62
Natural Killer Cells, donor2	11311-117C6	4.52	5.73	0.30	0.00	0.00	0.60
Natural Killer Cells, donor3	11387-118C1	7.18	7.73	0.55	0.37	0.37	0.18
Neural stem cells, donor1	11275-116H6	13.43	13.79	1.45	1.81	1.09	1.45
Neural stem cells, donor2	11352-117H2	15.41	23.11	3.85	0.00	1.93	1.93
Neurons, donor1	11494-119E9	15.93	27.31	2.28	0.00	5.69	2.28
Neurons, donor2	11574-120E8	15.63	17.83	2.20	1.10	1.10	1.54
Neurons, donor3	11655-122E8	5.76	13.98	2.47	0.00	2.47	0.00
Neutrophils, donor1	11233-116C9	12.99	4.64	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	14.49	0.00	0.00	2.90	0.00	5.80
Neutrophils, donor3	11390-118C4	18.94	3.67	0.61	1.22	0.61	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	24.22	11.75	3.80	1.54	1.07	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	20.51	9.44	3.58	0.65	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	17.65	13.84	4.81	1.80	0.80	0.60
Olfactory epithelial cells, donor1	11933-125I7	16.11	10.87	1.24	0.14	0.55	0.96
Olfactory epithelial cells, donor2	11934-125I8	18.38	12.74	3.18	1.45	1.01	1.30
Olfactory epithelial cells, donor3	11935-125I9	18.73	13.73	2.50	0.57	1.02	0.68
Olfactory epithelial cells, donor4	11936-126A1	19.48	14.80	2.14	0.29	0.58	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	16.85	10.83	3.61	1.20	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	23.61	13.83	4.25	1.06	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	28.58	22.86	9.14	2.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	13.03	8.69	1.86	0.00	0.00	0.62
Osteoblast, donor1	11277-116H8	34.59	19.54	4.30	2.74	2.35	1.56
Osteoblast, donor2	11354-117H4	21.77	24.58	4.21	2.11	0.70	1.40
Osteoblast, donor3	11426-118G4	33.95	16.88	5.15	2.13	1.78	1.96
Pancreatic stromal cells, donor1	11249-116E7	29.65	23.92	5.22	2.44	1.77	0.93
Pericytes, donor1	11491-119E6	24.59	23.92	9.12	1.67	1.45	1.34
Pericytes, donor2	11571-120E5	21.96	19.47	6.56	1.13	1.36	0.68
Pericytes, donor3	11652-122E5	26.65	22.18	6.92	3.05	1.83	1.63
Perineurial Cells, donor1	11499-119F5	28.71	15.14	5.09	1.24	0.90	0.90
Perineurial Cells, donor2	11579-120F4	18.95	9.57	2.39	0.92	0.83	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	13.07	7.65	1.59	0.96	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.86	6.86	0.49	0.49	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.67	7.12	0.78	0.52	0.26	0.13
Placental Epithelial Cells, donor1	11278-116H9	18.89	9.57	4.30	5.74	1.91	0.96
Placental Epithelial Cells, donor2	11355-117H5	18.85	19.96	4.44	3.33	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	16.10	8.64	4.12	2.16	0.98	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	29.75	17.40	0.63	1.90	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	21.20	18.01	3.00	1.13	0.38	1.69
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.06	17.36	1.70	2.35	0.13	0.39
Preadipocyte - breast, donor2	11328-117E5	29.94	17.11	2.70	2.03	2.48	0.90
Preadipocyte - omental, donor1	11468-119C1	19.29	17.05	2.88	2.45	0.85	1.70
Preadipocyte - omental, donor2	11329-117E6	19.64	14.40	3.49	1.75	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	25.64	16.33	4.15	2.72	1.00	1.15
Preadipocyte - perirenal, donor1	11469-119C2	15.75	5.91	7.87	2.95	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	19.96	13.51	2.15	0.61	1.54	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	30.99	24.61	7.44	1.77	2.30	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	32.52	16.35	5.28	2.55	1.70	1.36
Preadipocyte - visceral, donor1	11280-116I2	33.16	19.19	7.08	3.26	1.96	1.40
Preadipocyte - visceral, donor2	11357-117H7	25.31	13.81	5.06	3.68	2.30	0.46
Preadipocyte - visceral, donor3	11429-118G7	22.88	17.55	3.76	2.61	1.67	1.04
Prostate Epithelial Cells (polarized), donor1	11253-116F2	7.54	3.62	17.05	5.43	0.30	1.06
Prostate Epithelial Cells, donor2	11331-117E8	9.75	9.07	5.01	4.60	0.54	0.81
Prostate Epithelial Cells, donor3	11404-118D9	11.64	6.25	6.18	3.00	0.31	0.31
Prostate Stromal Cells, donor1	11254-116F3	23.46	23.46	4.78	2.39	1.82	2.16
Prostate Stromal Cells, donor2	11332-117E9	21.16	24.92	1.26	1.26	2.51	1.79
Prostate Stromal Cells, donor3	11405-118E1	23.98	18.25	3.13	1.36	1.36	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.91	17.15	3.65	4.01	0.36	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	17.67	11.23	3.05	3.60	0.83	1.11
Renal Epithelial Cells, donor1	11517-119H5	21.81	15.22	4.06	4.06	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	27.74	4.98	3.56	4.27	1.42	2.13
Renal Epithelial Cells, donor3	11678-122H4	20.96	6.78	1.48	2.12	0.85	0.64
Renal Glomerular Endothelial Cells, donor1	11514-119H2	11.57	5.45	0.68	2.04	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.45	4.18	1.35	3.10	0.67	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.54	7.33	1.78	2.00	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	27.28	6.65	2.00	2.66	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	23.99	15.63	4.18	3.08	0.44	1.54
Renal Mesangial Cells, donor2	11598-120H5	23.83	11.29	3.13	3.13	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	26.91	10.54	4.16	3.61	1.39	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	17.98	17.45	3.49	3.22	1.61	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	15.18	15.18	2.11	3.37	0.84	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	20.63	8.10	1.54	2.31	0.77	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	14.26	16.85	5.70	2.59	1.04	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	19.33	12.51	4.26	1.14	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	18.52	16.47	5.15	1.03	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	13.05	12.29	4.52	2.01	1.00	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.84	14.17	2.81	1.34	0.67	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	6.25	1.79	5.36	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	4.95	6.60	8.26	1.10	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.22	5.80	2.32	1.16	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	5.07	4.94	2.34	0.52	0.65	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	8.54	7.35	2.09	0.79	0.40	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	12.16	8.14	1.90	1.12	0.78	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	10.54	8.19	3.47	1.24	2.11	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	10.49	5.48	1.40	0.58	0.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	9.94	7.63	3.47	0.23	0.92	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	6.02	5.75	2.05	0.55	0.82	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	7.26	6.66	2.27	0.30	0.76	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	12.18	5.91	2.87	1.08	0.72	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	7.32	7.60	3.16	0.86	0.86	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	8.05	5.04	3.11	0.86	0.97	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	8.41	9.74	3.98	0.89	0.89	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	4.40	5.54	2.10	0.00	0.57	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	7.64	5.40	2.98	0.84	1.12	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	9.21	6.39	2.44	0.94	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	4.91	5.97	2.26	0.93	0.53	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	8.27	6.42	2.34	0.78	0.78	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	10.88	8.98	3.25	1.34	1.91	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	5.77	6.41	1.82	0.64	0.75	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	9.81	8.97	1.96	0.28	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	9.06	9.91	2.56	0.85	1.03	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	5.65	8.02	1.82	0.36	1.82	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	7.24	5.64	2.45	0.74	0.37	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	11.28	8.60	3.09	0.67	0.94	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	8.02	11.09	2.36	0.94	0.47	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	7.14	6.94	3.17	0.20	1.79	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	10.06	8.42	1.87	0.94	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.09	8.92	2.28	1.24	1.04	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.85	7.74	0.88	0.88	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	8.56	7.10	2.92	1.04	1.25	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	5.65	8.08	2.56	0.81	1.21	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	8.17	6.30	1.87	1.02	1.02	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	9.25	7.71	2.70	0.77	1.54	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	7.74	9.63	2.41	1.72	1.38	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.19	5.35	1.37	0.27	0.69	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.52	7.88	2.63	1.48	0.82	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	4.94	4.94	1.36	1.70	1.02	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	12.13	7.40	3.26	1.18	1.33	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	9.06	4.80	3.73	0.53	0.53	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	7.47	5.53	2.63	1.24	1.11	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.24	6.67	0.95	0.24	0.95	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	8.46	6.05	4.03	0.81	0.60	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.00	7.06	3.20	1.32	0.75	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	9.43	5.24	4.19	0.70	1.75	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.16	5.74	5.44	0.60	0.91	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	5.75	6.36	2.33	1.22	0.86	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	10.48	8.30	6.26	1.02	0.29	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.13	5.48	5.48	1.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	3.32	5.73	1.81	0.90	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	10.86	5.43	4.98	1.58	0.23	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	13.48	7.49	8.99	2.10	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	7.32	7.79	4.60	1.18	0.47	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	10.89	7.26	6.40	1.07	1.28	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	7.81	7.81	6.01	1.80	0.60	0.00
Schwann Cells, donor1	11498-119F4	25.58	22.00	5.83	1.88	2.44	0.94
Schwann Cells, donor2	11578-120F3	20.41	17.01	3.40	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	21.91	16.43	5.04	0.66	2.19	0.88
Sebocyte, donor1	11220-116B5	18.62	8.22	10.41	6.57	1.64	0.55
Sebocyte, donor2	11301-117B5	10.11	3.68	4.60	4.14	0.00	1.38
Sebocyte, donor3	11378-118B1	25.56	9.48	8.04	3.30	0.82	0.21
Sertoli Cells, donor1	11255-116F4	44.73	24.85	3.31	3.31	1.66	1.66
Sertoli Cells, donor2	11333-117F1	11.30	14.12	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	20.76	13.64	6.16	1.67	1.23	1.14
Skeletal Muscle Cells, donor2	11358-117H8	13.73	10.12	7.95	0.72	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	20.06	13.38	10.03	1.67	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	22.78	14.14	5.03	2.98	0.94	1.10
Skeletal Muscle Cells, donor5	11455-119A6	17.99	13.23	3.72	3.12	1.49	0.59
Skeletal Muscle Cells, donor6	11459-119B1	22.62	16.62	6.16	1.39	1.23	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.08	15.37	6.05	3.91	0.63	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.82	14.13	4.57	2.14	0.43	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.83	15.68	5.65	2.38	1.88	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	26.20	12.05	3.79	1.52	1.52	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.09	8.69	6.51	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.59	14.31	4.54	1.38	0.96	0.96
Skin - palm, donor1	10286-104F7	8.06	10.74	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.37	3.03	2.59	4.90	0.86	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.09	9.81	6.54	2.45	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.26	4.15	3.38	2.47	0.39	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	10.98	7.23	5.28	3.06	0.83	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	5.34	3.52	3.09	1.41	0.56	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	12.69	4.23	14.17	5.50	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	6.00	5.40	4.42	2.10	0.30	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	25.61	33.02	6.79	5.55	4.01	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.78	13.78	5.11	2.89	0.89	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	28.22	17.63	2.35	1.76	1.18	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	28.51	15.91	3.09	3.76	1.33	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	31.90	23.23	6.69	4.33	1.58	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	22.40	10.82	6.18	3.86	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	10.01	13.01	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	28.74	19.96	5.86	4.52	2.13	2.26
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	32.36	25.49	6.21	1.77	1.33	1.77
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	20.36	13.19	5.63	4.23	1.54	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	32.56	12.05	4.56	3.91	0.65	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	28.65	23.63	4.13	2.07	2.95	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	21.35	16.66	1.28	3.27	1.14	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	38.23	30.09	3.25	3.09	1.79	2.77
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	14.00	13.40	4.26	0.61	0.61	1.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	27.28	14.14	4.04	1.26	0.51	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	18.36	12.24	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.78	8.58	1.43	1.43	2.38	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	21.09	12.09	2.36	2.36	0.74	1.47
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.08	10.98	1.94	1.94	1.51	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	20.78	15.01	4.51	2.31	0.94	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	32.33	21.66	6.81	5.10	2.01	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	19.40	9.70	4.31	3.23	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	19.72	12.25	7.17	3.59	1.49	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	27.65	27.65	4.10	3.07	1.37	2.39
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	16.02	8.80	5.10	1.10	0.39	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	43.58	34.32	6.14	4.53	3.12	3.12
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	29.35	20.48	6.83	4.10	2.28	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	20.53	18.72	6.04	1.81	0.60	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	21.19	20.40	6.36	1.32	1.85	2.12
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.78	18.78	3.06	1.33	1.07	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.28	17.91	2.75	1.88	0.50	1.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	24.35	14.71	2.54	1.01	0.51	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.88	19.15	6.03	3.92	1.51	1.51
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	33.01	14.25	4.50	1.50	2.25	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	96.92	10.34	0.00	3.88	14.21	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	23.25	17.21	6.05	3.72	0.93	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	34.33	19.69	6.56	3.03	0.50	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	17.55	19.43	5.33	1.88	2.19	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	29.79	14.16	6.49	5.31	0.88	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	30.82	17.41	5.91	2.92	2.17	1.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	19.62	9.34	3.27	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	21.01	17.27	5.76	4.32	2.45	2.16
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.46	15.30	4.84	2.04	1.78	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.92	12.60	4.32	1.69	1.50	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	25.15	13.42	5.73	2.10	0.84	0.98
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.23	11.98	3.85	2.09	1.26	1.51
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	25.71	12.86	1.43	1.90	1.43	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	23.73	15.66	4.16	3.67	0.73	1.71
Smooth Muscle Cells - Uterine, donor1	11258-116F7	20.11	17.23	4.20	1.77	1.10	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	20.19	19.31	2.05	1.76	1.17	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.91	12.24	1.75	0.58	0.19	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	15.60	14.54	3.17	1.32	0.53	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	14.13	17.48	3.35	0.74	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.43	24.08	6.83	3.59	2.87	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.05	23.85	3.69	2.27	1.14	1.70
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	12.21	18.51	3.15	1.18	0.39	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	21.59	14.73	4.32	1.02	1.02	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	18.77	7.99	3.59	0.40	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	15.47	15.88	4.60	1.67	1.67	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	19.25	16.96	3.21	0.46	3.21	0.92
Synoviocyte, donor1	11291-117A4	30.80	23.73	1.85	0.84	2.02	1.68
Synoviocyte, donor2	11368-117I9	29.00	17.60	5.53	0.84	1.01	1.01
Synoviocyte, donor3	11440-118H9	14.75	17.65	4.02	0.67	0.67	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	26.09	21.08	6.79	1.43	1.07	2.14
Trabecular Meshwork Cells, donor2	11612-122A1	13.87	27.75	3.96	5.95	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	25.70	20.61	4.86	2.32	1.62	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	14.05	4.87	7.81	4.30	0.57	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	9.66	3.48	2.71	2.71	0.39	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	5.73	5.15	4.01	5.15	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	18.08	12.55	4.06	0.98	0.12	0.74
Urethra, donor2	10319-105A4	12.59	8.99	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	16.74	11.16	2.92	5.58	1.86	0.80
Urothelial Cells, donor2	11600-120H7	15.22	6.81	3.20	3.61	0.00	0.80
Urothelial Cells, donor3	11681-122H7	17.42	5.27	2.29	1.83	0.92	0.46
Urothelial cells, donor0	11216-116B1	20.95	5.57	2.45	4.01	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	24.02	10.68	0.89	3.56	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	21.44	7.15	1.43	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	18.48	3.42	0.68	2.05	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	22.38	6.54	0.34	1.72	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	17.43	4.07	0.58	2.91	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	27.07	9.37	0.00	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	19.27	3.67	0.00	2.75	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	2.74	0.91	3.65	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	9.99	4.93	5.55	2.22	1.11	0.25
Wilms' tumor cell line:HFWT	10597-108E3	14.08	6.16	3.52	0.88	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	12.57	10.33	3.07	0.84	0.00	0.28
achilles tendon, donor2	10292-104G4	10.33	4.13	2.07	0.00	4.13	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	9.43	1.02	4.59	2.80	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	5.11	3.02	3.95	1.39	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	13.65	6.89	2.26	1.19	0.12	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	12.79	8.44	3.54	4.35	0.27	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	10.12	4.22	1.69	2.81	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	15.86	4.02	1.27	2.54	0.63	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.70	4.36	3.81	2.45	0.54	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	5.29	3.53	1.32	0.88	1.32	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	4.90	2.86	5.31	0.41	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	4.66	1.94	0.78	0.39	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	8.28	8.65	2.76	1.66	0.18	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	3.90	19.50	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	8.37	3.49	3.95	2.56	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	10.10	5.18	1.04	1.29	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	17.53	9.64	1.75	0.29	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	9.76	5.58	5.58	1.86	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.52	9.87	2.47	0.41	1.65	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	5.83	5.22	1.23	0.61	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	9.81	6.83	1.71	1.71	0.00	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	9.10	10.01	1.52	1.52	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	11.07	7.46	1.93	1.20	0.48	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	15.37	9.13	4.90	2.23	1.56	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	12.34	11.67	2.67	8.01	1.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	3.72	3.72	0.00	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	14.69	6.78	2.64	4.14	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	6.54	3.49	1.74	0.87	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	20.62	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	3.77	1.88	14.37	2.35	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	15.36	8.69	2.02	0.78	0.31	0.00
adipose, donor1	10184-103D4	7.04	7.62	4.10	2.35	0.59	0.00
adipose, donor2	10185-103D5	2.84	0.81	4.87	0.00	0.41	0.00
adipose, donor3	10186-103D6	9.26	4.08	3.81	0.27	0.82	1.36
adipose, donor4	10187-103D7	6.93	6.93	4.33	2.60	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	17.04	10.57	2.84	2.21	0.95	0.32
adrenal gland, adult, pool1	10081-102A9	25.46	18.19	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	6.27	1.60	6.27	1.60	0.67	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	15.01	12.51	1.79	0.36	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	20.63	6.26	4.87	1.62	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	32.12	7.78	3.04	2.03	1.01	0.68
amniotic membrane cells, donor3	12237-129G5	22.39	8.84	5.01	1.18	0.00	0.00
amygdala - adult, donor10196	10167-103B5	35.57	58.10	5.93	4.74	1.19	1.19
amygdala, adult, donor10252	10151-102I7	23.12	21.70	7.30	1.22	0.41	1.22
amygdala, newborn, donor10223	10360-105E9	14.85	20.33	4.20	0.97	1.61	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	24.70	7.13	8.02	2.67	0.51	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	10.15	5.74	6.84	7.28	1.99	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	14.36	13.03	2.00	2.00	0.67	1.00
aorta, adult, pool1	10052-101G7	24.52	8.04	1.37	0.00	0.78	0.39
appendix, adult	10189-103D9	20.18	10.09	1.55	3.10	0.00	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	7.22	5.50	6.88	2.75	0.34	0.34
artery, adult	10190-103E1	29.89	46.20	0.00	2.72	4.08	2.72
astrocytoma cell line:TM-31	10425-106D2	18.40	10.87	3.48	1.88	1.88	0.87
b cell line:RPMI1788	10427-106D4	16.21	8.92	5.06	3.57	1.04	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	35.24	24.69	3.05	4.44	1.39	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	22.92	23.82	10.42	8.43	1.39	2.08
bile duct carcinoma cell line:TFK-1	10496-107C1	7.87	10.88	2.34	1.84	0.33	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	14.54	8.95	2.80	1.12	0.56	1.12
bladder, adult, pool1	10011-101C2	18.36	7.39	0.65	1.20	0.87	1.30
blood, adult, pool1	10053-101G8	4.43	8.86	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	10.28	9.42	0.00	1.71	0.00	0.00
bone marrow, adult	10192-103E3	30.37	15.52	0.67	2.70	2.70	0.67
brain, adult, donor1	10084-102B3	34.85	31.78	7.18	3.08	0.00	3.08
brain, adult, pool1	10012-101C3	48.22	33.96	6.01	3.01	2.67	2.34
brain, fetal, pool1	10085-102B4	18.70	26.71	5.34	0.00	8.01	2.67
breast carcinoma cell line:MCF7	10482-107A5	13.88	9.91	0.66	1.65	0.33	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	5.37	1.62	7.24	1.25	0.37	0.25
breast, adult, donor1	10080-102A8	10.73	5.68	1.26	1.26	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	16.01	13.97	12.96	2.16	0.51	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	2.16	2.16	5.88	1.24	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	15.65	5.30	11.05	2.30	0.46	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	13.56	8.23	5.33	1.45	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	10.81	9.87	19.75	3.76	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	7.11	4.92	2.52	1.53	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	12.04	5.07	3.80	1.27	0.95	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	10.38	16.77	8.52	1.06	0.53	1.86
caudate nucleus - adult, donor10196	10177-103C6	21.88	17.27	5.76	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	24.43	14.72	5.69	2.34	1.17	0.67
caudate nucleus, adult, donor10258	10379-105H1	23.69	16.05	1.53	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	15.02	12.82	1.83	1.83	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	37.87	14.57	2.91	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	23.06	10.46	6.19	1.49	0.21	0.21
cerebellum, adult, pool1	10083-102B2	24.15	18.97	3.10	0.69	1.72	1.03
cerebellum, newborn, donor10223	10357-105E6	6.64	19.93	5.81	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	40.59	36.06	5.55	2.52	0.76	2.27
cerebrospinal fluid, donor2	10294-104G6	6.58	8.77	0.00	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	10.93	14.52	30.05	4.74	0.14	0.72
cervical cancer cell line:ME-180	10553-107I4	14.58	7.79	4.81	3.65	0.66	0.66
cervix, adult, pool1	10013-101C4	23.20	11.02	2.31	1.26	0.42	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	14.35	19.51	1.53	0.98	0.84	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	2.61	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	10.81	11.18	16.78	3.98	0.87	0.75
choriocarcinoma cell line:SCH	10785-110H2	12.69	17.00	7.64	1.11	0.74	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	8.54	12.10	13.52	3.79	0.95	0.47
chorionic membrane cells, donor1	12238-129G6	13.11	4.56	5.70	0.85	0.00	0.57
chorionic membrane cells, donor2	12239-129G7	16.31	10.84	5.07	1.99	0.99	0.60
chorionic membrane cells, donor3	12240-129G8	11.54	2.20	7.14	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	6.06	1.01	3.03	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.37	4.99	2.31	0.96	1.15	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	8.87	2.11	2.75	1.69	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	2.57	3.60	4.37	0.77	0.77	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1.45	2.66	4.84	1.69	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.65	4.28	2.65	0.41	0.20	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	5.01	6.18	4.42	0.88	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	6.52	3.65	3.65	1.04	1.56	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	28.12	10.97	8.00	6.63	0.46	1.14
clear cell carcinoma cell line:TEN	10636-108I6	12.15	16.31	2.26	1.04	0.52	0.87
colon carcinoma cell line:CACO-2	10513-107D9	3.66	5.13	12.45	2.38	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	9.50	5.70	22.80	3.42	1.14	0.76
colon, adult, donor1	10082-102B1	15.47	3.57	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	18.92	8.11	1.88	1.29	0.24	0.35
colon, fetal, donor1	10070-101I7	14.83	4.33	1.85	1.24	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	13.75	4.58	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2.97	3.82	2.97	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3.77	3.02	3.62	2.72	0.45	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	3.95	2.96	2.82	1.27	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	32.95	28.53	7.19	1.22	1.33	1.00
cruciate ligament, donor2	10295-104G7	12.16	6.48	0.81	1.62	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	10.43	7.22	3.21	1.61	0.00	0.80
diencephalon, adult	10193-103E4	33.12	26.88	4.32	2.88	2.16	2.16
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	11.02	2.07	2.53	2.07	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.98	24.62	13.59	7.95	1.03	2.56
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	12.28	16.13	4.33	3.61	0.96	0.96
ductus deferens, adult	10196-103E7	17.94	8.47	2.99	0.50	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	8.64	1.44	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	18.39	12.51	5.89	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	24.61	18.25	1.07	0.41	0.99	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	8.44	14.21	14.43	6.66	2.00	2.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.61	18.77	3.73	3.58	1.15	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	4.93	9.25	4.93	1.23	0.00	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	9.08	6.05	3.63	1.21	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	5.25	8.03	6.17	0.93	0.00	1.23
embryonic pancreas cell line:2C6	10603-108E9	1.31	9.19	7.88	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	14.75	8.72	5.70	1.01	1.01	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	20.84	17.58	4.53	0.72	0.72	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	19.46	12.38	2.41	3.86	1.29	1.77
epidermoid carcinoma cell line:A431	10426-106D3	16.45	7.67	3.67	4.89	0.22	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	8.69	6.93	9.90	6.82	0.77	0.66
epididymis, adult	10197-103E8	21.35	18.00	3.35	0.42	1.26	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	15.97	8.34	1.24	0.35	0.18	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.54	3.15	0.79	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	15.33	17.43	4.19	3.41	1.18	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	13.58	15.55	4.63	2.56	0.79	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	14.68	22.18	4.37	2.69	1.23	0.78
esophagus, adult, pool1	10015-101C6	24.00	10.72	3.40	2.44	0.42	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	26.93	11.27	1.63	2.13	1.13	0.50
eye - muscle inferior rectus, donor1	10272-104E2	12.07	12.07	0.00	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	12.63	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	19.35	17.86	1.49	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	21.78	8.03	3.44	0.00	1.15	2.29
eye - vitreous humor, donor1	10268-104D7	11.66	10.20	2.91	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	34.32	16.02	3.05	2.54	0.76	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	13.59	5.13	5.26	3.21	0.77	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	9.02	10.21	14.96	5.22	1.19	0.71
frontal lobe, adult, pool1	10040-101F4	54.14	41.94	6.57	3.10	1.78	2.44
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	6.61	2.10	6.91	2.10	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	29.17	11.61	4.02	3.66	1.01	1.01
gall bladder, adult	10198-103E9	23.66	11.35	2.90	2.17	0.24	0.97
gamma delta positive T cells, donor1	11937-126A2	15.57	5.37	0.54	2.15	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	14.19	8.96	1.12	1.87	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	7.82	10.77	10.14	2.32	0.42	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	26.69	17.99	10.44	2.32	1.16	0.97
gastric cancer cell line:AZ521	10549-107H9	13.61	12.46	8.03	5.90	1.15	1.48
gastric cancer cell line:GSS	10560-108A2	14.64	1.83	2.75	2.75	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	13.02	4.11	2.51	2.28	0.23	1.14
giant cell carcinoma cell line:LU65	10487-107B1	6.20	7.46	5.62	1.15	0.46	1.03
giant cell carcinoma cell line:Lu99B	10433-106E1	7.14	6.16	4.62	0.84	0.28	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	9.73	8.73	6.24	2.49	0.75	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.34	3.06	1.27	1.16	0.63	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	7.72	2.67	1.54	0.56	0.42	0.56
glioblastoma cell line:T98G	10485-107A8	16.56	8.28	6.84	0.99	0.88	1.10
glioma cell line:GI-1	10413-106B8	11.13	7.91	3.51	1.76	0.59	0.88
globus pallidus - adult, donor10196	10175-103C4	15.31	16.76	3.64	0.73	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	25.14	14.65	7.32	1.71	0.73	1.46
globus pallidus, adult, donor10258	10367-105F7	23.28	24.65	2.74	1.37	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	12.79	14.39	1.07	1.07	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	58.73	26.92	0.00	9.79	2.45	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	5.23	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	10.88	12.16	2.24	0.96	0.00	1.28
hIPS +CCl2, biol_rep1	14383-156B9	11.94	10.10	1.84	0.46	1.38	1.38
hIPS +CCl2, biol_rep2	14384-156C1	8.23	12.80	7.77	1.83	1.37	0.46
hIPS +CCl2, biol_rep3	14385-156C2	11.59	12.88	7.09	0.00	1.29	1.93
hIPS, biol_rep1	14380-156B6	7.19	20.12	1.44	1.44	0.00	1.44
hIPS, biol_rep2	14381-156B7	5.49	13.72	4.12	1.37	2.74	0.69
hIPS, biol_rep3	14382-156B8	19.86	37.52	6.62	3.31	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	4.88	1.72	6.61	3.16	0.29	0.29
heart - mitral valve, adult	10205-103F7	20.63	11.66	1.20	0.30	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	26.93	13.86	1.31	0.78	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	14.15	7.49	2.50	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	29.38	16.73	2.24	1.63	1.02	0.82
heart, adult, diseased, donor1	10051-101G6	32.79	14.90	0.43	2.55	0.85	0.43
heart, adult, pool1	10016-101C7	28.52	18.63	1.38	1.38	0.23	1.61
heart, fetal, pool1	10046-101G1	36.55	10.27	2.46	2.98	0.82	1.03
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.30	7.40	1.85	2.16	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	3.57	7.14	7.14	2.38	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	13.37	5.52	6.63	5.30	0.77	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	13.35	6.07	8.13	7.16	0.73	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	16.77	6.57	7.58	5.25	0.71	0.40
hepatoma cell line:Li-7	10484-107A7	10.68	7.79	2.89	1.22	1.11	1.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.45	3.32	10.05	4.92	0.50	0.50
hippocampus - adult, donor10196	10169-103B7	13.25	21.77	0.95	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	18.98	17.55	7.14	1.63	1.22	1.84
hippocampus, adult, donor10258	10374-105G5	23.90	38.84	4.98	2.49	2.49	2.49
hippocampus, newborn, donor10223	10363-105F3	11.98	26.44	2.82	1.06	1.76	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	10.38	27.47	7.32	1.83	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	13.94	15.51	4.12	1.57	0.39	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	16.76	16.25	4.82	1.52	0.76	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.64	5.64	2.82	0.56	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5.42	5.94	3.87	0.52	0.77	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	6.07	4.93	4.93	0.76	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	11.39	7.88	3.21	0.29	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	9.05	6.03	5.39	1.08	0.22	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.84	10.01	2.50	1.25	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	10.89	10.89	1.42	0.95	0.24	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	10.77	11.09	1.77	0.80	0.64	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	16.16	6.73	2.69	1.35	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	12.83	13.30	4.07	1.41	0.47	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	19.65	14.25	5.90	0.98	1.97	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	12.22	15.71	5.24	1.75	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.78	5.54	4.39	0.76	0.38	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	9.16	3.05	3.92	0.87	0.44	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.99	6.00	3.00	0.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.41	4.90	5.09	0.19	0.38	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.18	4.55	7.28	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.46	5.01	6.26	0.31	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.68	8.17	3.10	0.33	0.82	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	7.84	7.55	3.19	0.58	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.06	7.77	3.59	0.60	0.00	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	14.23	9.24	2.77	1.48	0.37	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	15.12	12.84	7.42	1.71	0.86	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	11.02	17.97	5.31	2.86	0.82	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	10.91	5.99	4.22	0.35	1.76	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	9.19	4.12	3.80	1.27	0.63	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	9.38	4.24	2.12	1.51	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	10.86	8.79	5.69	2.59	1.03	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	13.95	3.98	3.98	0.00	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	14.37	8.98	3.59	0.77	1.03	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.78	13.80	3.83	1.79	0.51	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	8.33	0.00	0.00	1.51	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.43	11.09	1.01	1.68	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	10.14	8.21	6.52	1.21	1.93	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	12.03	9.80	4.90	0.45	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	13.66	11.71	6.83	3.41	0.98	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	6.11	5.20	3.97	0.61	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	9.76	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	10.92	3.64	4.63	1.65	0.33	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	8.76	12.04	7.66	3.28	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	9.41	9.05	3.62	0.36	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	8.54	8.54	2.49	1.42	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	8.35	5.97	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	13.54	12.46	4.47	0.68	0.54	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	9.43	7.54	2.42	0.00	0.81	0.27
immature langerhans cells, donor1	11904-125F5	4.84	7.26	0.00	0.97	0.73	0.00
immature langerhans cells, donor2	11905-125F6	5.54	5.54	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	57.16	45.80	6.62	3.22	2.46	3.03
keratoacanthoma cell line:HKA-1	10791-110H8	16.26	4.23	10.08	2.28	0.65	0.00
kidney, adult, pool1	10017-101C8	24.93	20.63	4.91	2.40	1.00	1.30
kidney, fetal, pool1	10045-101F9	23.91	13.58	3.32	1.77	0.71	1.13
large cell lung carcinoma cell line:IA-LM	10509-107D5	76.27	28.12	5.68	7.67	2.98	4.12
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.58	8.43	2.35	1.66	0.41	1.11
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	4.59	6.79	6.79	0.92	0.37	0.92
left atrium, adult, donor1	10079-102A7	21.25	10.90	1.09	1.09	0.00	1.09
left ventricle, adult, donor1	10078-102A6	23.26	9.61	1.01	1.52	1.01	1.01
leiomyoblastoma cell line:G-402	10721-110A1	11.77	6.02	1.92	1.64	0.27	0.27
leiomyoma cell line:10964C	10569-108B2	26.58	30.18	8.26	3.95	1.44	0.36
leiomyoma cell line:15242A	10570-108B3	19.02	25.00	3.80	2.17	2.17	2.17
leiomyoma cell line:15425	10571-108B4	25.74	28.65	6.31	3.16	1.70	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	19.05	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	7.32	4.18	0.00	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	6.97	1.89	1.77	2.48	0.47	1.06
liposarcoma cell line:KMLS-1	10782-110G8	22.34	16.71	5.15	3.28	1.09	1.09
liposarcoma cell line:SW 872	10726-110A6	6.82	6.94	6.82	1.10	0.85	0.61
liver, adult, pool1	10018-101C9	21.23	18.80	2.43	2.76	0.65	1.46
liver, fetal, pool1	10086-102B5	15.99	5.64	0.00	2.82	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	16.77	16.04	4.23	1.46	1.31	1.60
locus coeruleus, adult, donor10252	10165-103B3	18.27	15.87	8.30	2.03	1.29	1.85
locus coeruleus, adult, donor10258	10375-105G6	33.86	24.55	5.64	2.26	0.56	2.26
locus coeruleus, newborn, donor10223	10362-105F2	10.52	15.56	5.05	0.84	1.68	0.42
lung adenocarcinoma cell line:A549	10499-107C4	5.12	3.60	7.20	0.83	0.42	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	31.02	13.79	6.20	2.07	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	15.42	3.56	1.05	0.53	0.53	0.40
lung, adult, pool1	10019-101D1	15.59	7.44	1.18	0.71	0.35	0.47
lung, fetal, donor1	10068-101I5	20.83	15.13	2.57	1.14	0.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	21.99	8.71	0.92	0.92	0.46	0.92
lymph node, adult, donor1	10077-102A5	11.83	4.26	0.95	1.42	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	16.44	9.42	5.04	4.82	1.53	1.97
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	12.07	8.00	1.51	2.41	0.60	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	13.59	7.65	8.49	6.80	0.00	1.70
mature adipocyte, donor1	12231-129F8	26.20	22.64	1.78	1.33	1.33	0.44
mature adipocyte, donor2	12232-129F9	16.81	25.53	4.15	0.83	0.83	1.66
mature adipocyte, donor3	12233-129G1	14.46	23.47	3.08	0.24	1.66	0.95
mature adipocyte, donor4	12234-129G2	15.27	14.74	1.32	0.53	0.79	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	13.10	14.53	6.43	1.19	1.91	3.34
medial frontal gyrus - adult, donor10196	10170-103B8	31.58	30.46	7.90	3.38	2.26	7.90
medial frontal gyrus, adult, donor10252	10150-102I6	24.46	20.23	6.80	2.57	0.92	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	45.11	43.52	5.08	2.22	2.86	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	18.77	30.71	2.99	0.00	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	39.83	38.64	7.09	4.39	2.03	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	26.74	17.19	6.37	2.33	2.12	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	65.49	1.93	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	22.97	40.92	3.59	1.44	1.79	1.08
medulla oblongata - adult, donor10196	10174-103C3	24.66	13.63	1.95	0.65	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	19.04	14.71	5.73	2.01	0.46	1.86
medulla oblongata, adult, pool1	10038-101F2	29.30	23.26	5.47	3.18	1.22	2.29
medulla oblongata, newborn, donor10223	10361-105F1	12.85	12.50	2.78	1.74	0.69	1.74
medulloblastoma cell line:D283 Med	10838-111E1	6.42	5.31	22.36	3.32	0.89	0.89
medulloblastoma cell line:ONS-76	10759-110E3	8.56	4.77	3.42	2.08	0.61	0.86
melanoma cell line:COLO 679	10514-107E1	14.23	18.11	7.91	2.44	1.44	1.87
melanoma cell line:G-361	10465-106H6	17.10	5.97	10.32	4.89	1.36	0.27
meningioma cell line:HKBMM	10691-109F7	17.37	4.52	4.88	1.45	1.09	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	10.57	3.52	3.52	1.76	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	17.11	15.81	9.33	3.89	2.07	2.59
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.48	17.80	3.68	1.53	1.53	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.27	11.45	5.09	1.09	1.45	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	18.63	17.81	4.56	2.90	0.83	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	22.76	17.00	5.20	1.55	1.40	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.14	16.75	2.12	1.35	0.77	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	20.13	1.39	3.47	0.69	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	10.81	17.16	4.63	2.57	0.69	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	18.86	19.21	2.65	1.50	1.04	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	19.10	12.07	5.70	2.52	1.33	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	18.77	13.10	3.65	4.19	1.49	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.94	13.37	1.99	1.42	1.14	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	15.15	12.84	4.94	1.98	0.33	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	20.20	14.11	1.80	1.66	1.25	1.25
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	23.74	13.96	3.84	1.75	2.09	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	22.05	15.31	5.10	2.04	1.63	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.25	16.18	1.80	3.24	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	18.10	11.90	3.62	1.55	1.14	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.33	18.70	2.05	0.68	0.91	1.82
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	16.36	21.40	5.87	4.62	1.26	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	19.28	15.69	4.18	2.24	1.34	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	14.62	10.68	2.45	1.93	0.70	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	16.94	13.62	1.47	0.37	1.84	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.02	16.60	3.72	3.15	1.43	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.00	19.79	2.11	1.68	1.26	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.83	15.98	3.20	1.83	2.28	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.07	13.81	4.09	1.53	1.02	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.34	14.66	2.88	1.05	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.96	12.94	2.16	2.16	1.54	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	22.83	14.83	2.12	0.71	0.94	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	20.98	12.52	2.71	2.71	0.68	2.03
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.83	14.15	3.54	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.00	18.54	3.71	0.93	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	24.52	21.05	4.61	2.31	0.58	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	29.67	17.62	2.68	1.34	1.12	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.99	15.62	4.09	1.44	0.72	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.00	8.80	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.82	14.77	2.69	1.68	0.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	26.20	14.74	2.05	2.05	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	19.76	17.18	6.44	1.29	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	5.47	32.81	0.00	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	15.49	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	22.09	15.59	1.62	1.30	1.30	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	17.46	2.91	2.91	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	20.79	16.53	5.33	3.73	2.67	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	10.63	1.64	0.82	0.82	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	21.77	16.71	3.89	1.55	1.17	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	12.59	2.10	8.39	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	20.86	1.99	0.00	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.35	13.05	1.78	0.59	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	15.84	2.44	1.22	1.22	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	28.50	15.20	1.27	1.27	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.56	8.62	2.76	2.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	8.60	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	23.95	3.99	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	0.00	3.44	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.89	4.07	2.44	0.81	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	3.18	5.56	1.59	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	11.79	7.07	3.54	0.00	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.91	4.36	2.49	0.94	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	4.01	5.35	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	33.11	26.02	2.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	12.84	7.70	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	17.90	2.07	0.00	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.82	32.66	4.95	0.49	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	35.89	3.36	1.12	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	18.45	25.44	2.54	0.64	1.27	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	49.16	8.87	0.81	2.42	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	61.06	13.08	0.00	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	53.22	8.87	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	29.74	9.71	1.82	1.21	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	36.15	18.08	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	13.18	34.59	7.41	1.65	0.00	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.48	15.87	2.58	0.79	0.40	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	18.17	18.17	4.22	0.65	0.97	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	15.28	24.45	4.07	1.02	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	12.38	1.55	0.00	0.77	3.09
mesothelioma cell line:ACC-MESO-1	10493-107B7	11.34	11.81	4.96	3.07	1.89	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	3.71	1.16	0.00	0.23	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	11.41	6.78	2.26	1.44	0.31	0.72
mesothelioma cell line:Mero-25	10850-111F4	15.43	12.03	14.75	5.67	1.59	1.82
mesothelioma cell line:Mero-41	10851-111F5	25.67	11.73	2.20	1.71	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	16.39	11.74	6.86	3.32	0.44	0.44
mesothelioma cell line:Mero-82	10853-111F7	9.46	6.31	5.52	1.84	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	18.38	6.98	3.92	2.89	1.02	0.85
mesothelioma cell line:Mero-84	10855-111F9	20.22	5.31	2.53	2.02	0.51	0.76
mesothelioma cell line:Mero-95	10856-111G1	10.77	7.04	6.83	2.07	0.41	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	16.23	11.26	8.94	4.80	0.83	0.83
mesothelioma cell line:NCI-H226	10846-111E9	7.78	11.40	1.81	1.27	0.18	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	19.82	13.15	12.81	2.39	0.68	0.51
mesothelioma cell line:NCI-H28	10845-111E8	12.21	8.91	4.58	1.78	0.25	0.76
mesothelioma cell line:No36	10857-111G2	15.66	9.79	7.83	5.87	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	7.86	11.11	6.50	2.98	0.27	0.54
migratory langerhans cells, donor1	11901-125F2	9.60	3.26	0.00	0.96	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	13.43	5.25	0.37	0.37	0.73	0.37
migratory langerhans cells, donor3	11903-125F4	22.44	2.15	0.18	1.79	0.72	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.53	9.14	8.81	0.98	0.33	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.11	12.29	4.87	2.76	1.48	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	11.52	15.43	5.53	5.07	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.32	2.66	1.90	0.19	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	10.53	14.78	2.22	0.37	0.18	0.55
myeloma cell line:PCM6	10474-106I6	18.78	4.94	1.19	2.57	0.40	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	12.17	11.16	2.54	0.51	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.30	16.28	12.55	1.37	1.37	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.25	9.58	9.69	5.57	1.34	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.66	8.31	7.65	4.04	0.44	0.51
nasal epithelial cells, donor2	12227-129F4	22.08	5.52	7.18	2.21	0.55	1.10
neuroblastoma cell line:CHP-134	10508-107D4	6.44	4.37	12.42	0.92	0.69	1.15
neuroblastoma cell line:NB-1	10539-107G8	24.51	18.71	7.30	5.80	1.68	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	8.01	5.69	10.76	1.48	1.05	0.84
neuroblastoma cell line:NH-12	10555-107I6	8.94	9.50	11.37	2.80	0.56	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	15.42	9.01	2.37	1.42	0.47	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	23.12	16.95	6.49	1.58	0.79	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	21.33	12.88	2.42	2.42	0.81	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	5.09	1.91	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	13.57	11.98	2.93	1.33	1.60	0.27
neutrophil PMN, donor1	12133-128D9	59.50	59.50	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	5.58	0.85	7.10	0.51	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	32.02	5.60	6.40	4.80	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.40	15.39	2.24	1.28	2.24	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.44	17.61	3.94	2.89	1.31	1.31
nucleus accumbens, adult, pool1	10037-101F1	48.74	34.96	7.22	3.09	2.34	1.78
occipital cortex - adult, donor10196	10172-103C1	41.21	43.27	4.12	4.12	2.06	4.12
occipital cortex, adult, donor10252	10163-103B1	18.52	15.57	5.90	0.81	1.34	1.61
occipital cortex, newborn, donor10223	10355-105E4	24.75	44.77	5.10	0.73	1.82	1.09
occipital lobe, adult, donor1	10076-102A4	41.98	40.67	7.08	1.84	2.36	2.10
occipital lobe, fetal, donor1	10073-102A1	15.45	17.16	3.00	0.00	1.29	1.29
occipital pole, adult, pool1	10036-101E9	51.01	48.49	5.68	3.63	1.81	2.37
olfactory region, adult	10195-103E6	38.97	27.89	6.50	2.29	1.72	1.15
optic nerve, donor1	10277-104E7	10.01	12.01	0.00	0.00	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	20.50	9.91	16.97	10.14	0.46	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	23.91	23.22	17.59	9.07	1.24	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.26	9.48	1.35	0.85	0.85	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	9.59	5.66	2.31	0.92	0.58	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	19.99	11.76	2.94	1.18	0.59	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	7.47	5.61	1.87	2.80	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	9.54	16.54	2.97	1.48	0.85	1.91
ovary, adult, pool1	10020-101D2	15.99	11.36	1.14	0.70	0.79	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	13.57	4.77	3.85	4.03	0.73	0.37
pancreas, adult, donor1	10049-101G4	26.34	14.11	0.94	0.94	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	2.80	2.52	6.71	0.84	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	13.46	11.24	8.52	3.41	1.36	1.70
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	11.09	4.64	7.62	2.15	0.33	0.50
paracentral gyrus, adult, pool1	10035-101E8	50.25	46.58	7.69	3.94	1.37	2.38
parietal cortex, adult, donor10258	10373-105G4	24.96	27.89	8.07	0.00	0.73	2.20
parietal lobe - adult, donor10196	10171-103B9	26.33	33.86	6.58	1.88	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	23.37	21.09	5.42	0.86	1.14	1.71
parietal lobe, adult, pool1	10034-101E7	51.55	39.57	9.43	2.91	1.59	3.08
parietal lobe, fetal, donor1	10072-101I9	11.64	16.49	1.94	0.97	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	22.81	32.53	3.36	2.62	0.37	1.50
parotid gland, adult	10199-103F1	22.82	10.48	1.23	1.23	0.62	0.62
penis, adult	10200-103F2	25.24	16.11	1.07	1.07	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.32	10.97	3.16	0.19	0.37	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	17.19	17.05	2.91	2.04	0.87	0.73
pineal gland - adult, donor10196	10179-103C8	30.32	20.64	3.23	0.65	1.29	0.65
pineal gland, adult, donor10252	10160-103A7	38.49	14.21	6.51	3.55	1.78	1.78
pineal gland, adult, donor10258	10377-105G8	26.96	22.57	3.14	1.25	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	30.35	27.32	10.12	4.05	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	35.44	18.24	7.82	5.73	1.56	0.52
pituitary gland, adult, donor10258	10378-105G9	45.12	21.28	4.26	2.55	0.00	0.00
placenta, adult, pool1	10021-101D3	21.72	21.72	2.26	1.08	1.29	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	13.11	7.02	3.31	2.25	0.79	0.66
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	14.01	4.51	1.71	1.25	0.62	0.00
pons, adult, pool1	10033-101E6	45.87	37.18	7.92	5.77	2.75	3.18
postcentral gyrus, adult, pool1	10032-101E5	51.17	48.64	6.02	2.88	2.70	2.88
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	20.91	2.09	4.18	2.09	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	11.02	0.00	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	23.47	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	13.55	14.71	10.49	1.89	0.29	0.87
prostate cancer cell line:PC-3	10439-106E7	21.96	5.08	4.17	4.90	0.36	0.54
prostate, adult, pool1	10022-101D4	27.30	12.61	2.00	1.72	0.36	1.36
putamen, adult, donor10196	10176-103C5	40.13	24.79	5.19	1.89	1.18	1.89
putamen, adult, donor10252	10152-102I8	15.69	11.76	0.00	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	21.86	2.19	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	29.48	14.98	2.42	1.45	0.24	0.48
putamen, newborn, donor10223	10365-105F5	7.50	17.24	3.75	0.75	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	7.56	3.20	1.75	1.75	0.00	1.16
rectum, fetal, donor1	10067-101I4	19.47	2.78	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	27.35	11.02	4.45	3.60	0.85	2.12
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.87	0.83	2.07	2.07	0.00	0.41
retina, adult, pool1	10030-101E3	36.78	18.19	2.88	1.79	0.99	1.99
retinoblastoma cell line:Y79	10475-106I7	4.42	2.60	8.83	1.04	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	6.89	4.30	5.41	1.48	0.25	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	19.97	10.69	6.47	2.25	2.25	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	9.09	6.82	0.76	2.27	1.52	0.76
salivary acinar cells, donor1	11771-123I7	11.49	3.72	6.64	1.94	0.32	0.32
salivary acinar cells, donor2	11772-123I8	14.18	7.30	7.30	2.20	0.41	0.28
salivary acinar cells, donor3	11773-123I9	13.24	2.65	3.31	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	17.73	16.01	4.00	1.14	0.00	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	10.45	21.92	13.57	3.63	0.51	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.46	21.98	16.69	3.64	0.35	0.12
seminal vesicle, adult	10201-103F3	17.46	10.58	2.12	1.06	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	25.02	15.55	10.45	5.10	0.97	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	8.56	6.04	0.25	1.01	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	9.03	8.03	1.00	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	11.15	6.85	6.45	4.70	0.67	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	12.82	17.35	12.16	4.42	0.33	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.68	2.45	1.81	1.81	0.52	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	16.31	24.83	2.84	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	33.94	19.67	2.16	1.80	0.96	1.44
skeletal muscle, fetal, donor1	10066-101I3	23.12	7.04	1.01	1.01	1.01	1.01
skin, adult, donor1	10074-102A2	20.36	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	26.51	12.62	3.16	1.89	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	12.01	17.68	18.01	3.34	2.00	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.20	3.47	4.41	2.52	1.26	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	15.81	27.95	6.17	0.77	1.16	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	3.79	2.64	14.18	2.47	0.49	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	9.17	9.97	11.42	2.73	1.13	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	1.74	1.96	5.23	2.40	0.22	0.00
small intestine, adult, pool1	10024-101D6	19.83	10.15	3.46	2.03	0.12	0.72
small intestine, fetal, donor1	10064-101I1	20.15	3.69	2.70	0.25	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	24.11	10.77	7.18	5.13	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	20.93	10.60	0.78	0.52	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	13.67	2.95	6.70	4.02	0.54	0.00
spinal cord - adult, donor10196	10181-103D1	13.53	13.31	4.59	0.69	0.46	0.92
spinal cord, adult, donor10252	10159-103A6	14.98	10.25	5.91	2.76	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	8.99	31.13	4.15	0.00	1.38	2.08
spinal cord, fetal, donor1	10056-101H2	26.83	20.12	7.93	2.44	2.44	1.22
spinal cord, newborn, donor10223	10359-105E8	10.10	22.04	5.51	2.30	1.38	4.59
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	19.12	11.20	2.09	1.49	1.49	0.30
spleen, adult, pool1	10025-101D7	16.96	7.27	1.54	0.99	0.33	0.33
spleen, fetal, pool1	10044-101F8	22.64	9.30	1.27	1.27	0.40	0.72
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	16.77	2.90	3.83	2.69	0.52	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	10.06	10.82	8.54	2.28	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	22.71	14.68	2.10	1.05	1.40	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	9.77	6.25	14.46	5.47	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	23.07	57.07	5.40	3.38	1.46	4.50
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	12.28	4.66	5.08	4.66	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.88	7.62	0.42	0.42	0.42	0.42
stomach, fetal, donor1	10062-101H8	18.16	5.34	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	23.36	13.10	1.71	2.28	1.71	2.28
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	17.86	9.55	11.22	1.04	0.42	1.45
substantia nigra, adult, donor10258	10371-105G2	26.38	36.21	6.21	3.10	1.55	1.55
substantia nigra, newborn, donor10223	10358-105E7	11.31	9.19	2.83	0.00	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	12.84	5.50	3.90	1.15	1.83	1.15
temporal lobe, adult, pool1	10031-101E4	56.63	48.15	7.46	2.97	1.78	2.20
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.94	14.96	4.27	0.00	0.00	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	15.82	18.90	3.08	1.32	0.44	1.76
tenocyte, donor1	11763-123H8	36.66	28.28	4.19	2.79	1.75	1.05
tenocyte, donor2	11765-123I1	36.24	21.36	5.34	1.53	0.38	0.76
tenocyte, donor3	11768-123I4	25.95	25.21	3.71	1.85	1.48	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	16.32	12.24	13.77	3.57	1.70	1.87
teratocarcinoma cell line:NCR-G1	10798-110I6	36.38	34.22	17.57	4.01	3.08	2.93
teratocarcinoma cell line:PA-1	10807-111A6	9.45	6.04	7.13	3.41	0.77	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	15.61	12.19	1.14	1.90	1.27	1.65
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	9.08	8.32	13.61	3.40	0.76	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	6.76	5.67	3.05	2.84	0.87	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	10.10	37.78	29.96	0.98	3.58	3.26
testis, adult, pool1	10026-101D8	15.46	21.90	2.36	1.07	0.64	1.72
testis, adult, pool2	10096-102C6	11.28	32.03	2.26	0.45	2.26	1.80
thalamus - adult, donor10196	10168-103B6	35.33	23.18	2.21	1.10	1.10	1.10
thalamus, adult, donor10252	10154-103A1	19.22	9.22	6.25	1.09	0.47	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	13.86	60.05	4.62	6.16	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.82	18.28	4.94	3.29	0.66	2.96
thalamus, newborn, donor10223	10366-105F6	14.96	21.29	1.15	1.73	0.00	2.30
throat, adult	10209-103G2	23.22	14.73	2.00	1.75	1.25	1.75
throat, fetal, donor1	10061-101H7	24.38	14.02	1.52	0.91	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	21.26	16.89	5.56	1.99	0.79	0.60
thymus, adult, pool1	10027-101D9	12.92	4.87	0.89	0.99	0.30	0.20
thymus, fetal, pool1	10043-101F7	17.87	3.95	0.73	1.56	0.42	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	11.30	9.04	3.59	1.60	0.93	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	13.83	14.25	5.45	0.98	1.54	1.68
thyroid, adult, pool1	10028-101E1	27.34	12.32	3.17	2.71	0.28	1.96
thyroid, fetal, donor1	10060-101H6	21.88	11.07	2.64	2.37	0.26	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	0.00	6.16	3.08	0.00	3.08
tongue, adult	10203-103F5	27.91	17.68	2.56	3.26	1.16	1.16
tongue, fetal, donor1	10059-101H5	42.17	11.82	3.94	2.36	0.39	1.58
tonsil, adult, pool1	10047-101G2	27.05	10.32	2.60	2.80	0.50	0.90
trachea, adult, pool1	10029-101E2	21.43	12.35	2.13	2.45	0.74	1.39
trachea, fetal, donor1	10058-101H4	28.85	6.54	1.92	0.00	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	19.13	13.82	2.48	1.06	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	5.88	3.04	3.55	1.01	0.41	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	13.32	18.96	20.37	3.76	1.25	1.10
tridermal teratoma cell line:HGRT	10694-109G1	7.61	0.00	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.39	12.61	4.23	1.19	0.59	0.51
umbilical cord, fetal, donor1	10057-101H3	20.87	6.26	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	24.23	12.46	1.37	2.22	0.68	0.51
uterus, fetal, donor1	10055-101H1	19.45	11.77	2.05	1.02	0.51	0.51
vagina, adult	10204-103F6	5.17	5.17	1.94	0.65	0.65	0.00
vein, adult	10191-103E2	22.58	6.36	2.41	1.32	0.66	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.35	2.40	5.61	1.87	0.53	0.00